UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number: 811-02958

T. Rowe Price International Funds, Inc.

(Exact name of registrant as specified in charter)

100 East Pratt Street, Baltimore, MD 21202

(Address of principal executive offices)

David Oestreicher

100 East Pratt Street, Baltimore, MD 21202

(Name and address of agent for service)

Registrant’s telephone number, including area code:  (410) 345-2000

Date of fiscal year end:  October 31

Date of reporting period:  October 31, 2022

Item 1. Reports to Shareholders

(a) Report pursuant to Rule 30e-1

Highlights

and

Market

Commentary

Management’s

Discussion

of

Fund

Performance

Performance

and

Expenses

Financial

Highlights

Portfolio

of

Investments

Financial

Statements

and

Notes

Additional

Fund

Information

October

31,

2022

Annual

Report

For

more

insights

from

T.

Rowe

Price

investment

professionals,

go

to

troweprice.com

. 

T.

ROWE

PRICE

TCELX

China

Evolution

Equity

Fund

TRCLX

China

Evolution

Equity

Fund–I Class

T.

ROWE

PRICE

China

Evolution

Equity

Fund

HIGHLIGHTS

The

China

Evolution

Equity

Fund

generated

a

negative

total

return

but

outperformed

the

MSCI

China

All

Shares

Index

Net

in

the

12-month

period

ended

October

31,

2022.

Stock

selection

in

the

industrials

and

business

services

sector

added

the

most

value.

Conversely,

our

lack

of

exposure

to

the

financials

sector

detracted

from

relative

performance.

We

sought

to

build

a

more

balanced

portfolio

given

the

highly

uncertain

macro

environment.

We

invested

in

companies

that

we

considered

to

be

the

best

growth

assets;

companies

with

distinct

drivers

and

that

are

less

sensitive

to

a

weak

economy;

and

defensive,

attractively

valued

businesses.

With

better

visibility

of

China’s

exit

from

its

zero-COVID

strategy,

along

with

measures

supportive

of

the

property

sector,

we

expect

domestic

consumption

and

services

to

accelerate

in

2023.

This

will

likely

lead

to

broader

market

leadership,

which

bodes

well

for

bottom-up

investors.

Log

in

to

your

account

at

troweprice.com

for

more

information.

*

Certain

mutual

fund

accounts

that

are

assessed

an

annual

account

service

fee

can

also

save

money

by

switching

to

e-delivery.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Market

Commentary

1

Dear

Shareholder

Nearly

all

major

global

stock

and

bond

indexes

fell

sharply

during

your

fund’s

fiscal

year,

the

12-month

period

ended

October

31,

2022,

as

investors

contended

with

persistently

high

inflation,

tightening

financial

conditions,

and

slowing

economic

and

corporate

earnings

growth.

Double-digit

losses

were

common

in

equity

markets

around

the

world,

and

bond

investors

also

faced

a

historically

tough

environment

amid

a

sharp

rise

in

interest

rates.

Value

shares

declined

but

outperformed

growth

stocks

by

a

considerable

margin

as

equity

investors

turned

risk

averse

and

as

rising

rates

put

downward

pressure

on

growth

stock

valuations.

Emerging

markets

stocks

generally

underperformed

shares

in

developed

markets.

Meanwhile,

the

U.S.

dollar

strengthened

versus

most

currencies

during

the

period,

which

weighed

on

returns

for

U.S.

investors

in

international

securities. 

Energy

was

one

of

the

few

bright

spots

for

investors,

as

oil

prices

jumped

in

response

to

Russia’s

invasion

of

Ukraine

and

the

ensuing

commodity

supply

crunch,

which

helped

some

commodity-exporting

nations

in

Latin

America

and

the

Middle

East

deliver

positive

equity

returns.

While

results

varied

somewhat

by

region,

typically

defensive

sectors,

such

as

utilities,

consumer

staples,

and

health

care,

also

held

up

relatively

well.

Conversely,

diminishing

consumer

confidence

put

a

damper

on

returns

in

the

consumer

discretionary

sector,

and

information

technology

and

communication

services

shares

also

suffered

large

reversals. 

Inflation

remained

a

leading

concern

for

investors

throughout

the

period.

The

war

in

Ukraine

exacerbated

already

existing

supply

chain

problems,

and

other

factors,

such

as

the

impact

of

the

fiscal

and

monetary

stimulus

enacted

during

the

pandemic,

exerted

upward

pressure

on

consumer

demand

and

prices.

While

investors

held

out

hope

that

inflation

had

peaked

during

the

summer,

inflation

measures

remained

elevated.

In

the

U.S.,

the

core

consumer

price

index,

which

excludes

volatile

food

and

energy

costs,

hit

a

40-year

high

in

September,

while

eurozone

inflation

reached

a

record

level

in

October’s

preliminary

report.  

In

response

to

persistent

inflation,

global

central

banks

began

to

tighten

monetary

policy.

The

Federal

Reserve,

which

at

the

end

of

2021

had

forecast

that

it

would

only

need

to

raise

interest

rates

0.75

percentage

point

in

all

of

2022,

rapidly

shifted

in

a

hawkish

direction

and

raised

its

short-term

lending

benchmark

from

near

zero

in

March

to

a

target

range

of

3.75%

to

4.00%

by

T.

ROWE

PRICE

China

Evolution

Equity

Fund

2

early

November

and

indicated

that

additional

hikes

are

likely.

The

European

Central

Bank,

meanwhile,

raised

its

key

interest

rate

to

its

highest

level

since

2009. 

Bond

yields

increased

considerably

across

the

Treasury

yield

curve

as

the

Fed

tightened

monetary

policy,

with

the

yield

on

the

benchmark

10-year

U.S.

Treasury

note

climbing

from

1.55%

at

the

start

of

the

period

to

4.10%

at

the

end

of

October.

The

sharp

increase

in

yields

led

to

historically

weak

results

across

the

fixed

income

market,

with

the

Bloomberg

U.S.

Aggregate

Bond

Index

recording

its

worst

month

since

1980

in

September.

(Bond

prices

and

yields

move

in

opposite

directions.) 

On

a

positive

note,

the

U.S.

jobs

market

remained

resilient

during

the

period,

and

the

initial

reading

on

gross

domestic

product

for

the

third

quarter

returned

to

positive

territory

after

two

slightly

negative

quarters.

However,

recession

fears

also

grew

as

corporate

earnings

slowed

and

manufacturing

gauges

drifted

toward

contraction

levels. 

The

past

year

has

been

an

exceptionally

trying

time

for

investors

as

substantial

sell-offs

were

the

norm

across

both

stocks

and

bonds,

and

we

believe

that

volatility

may

continue

in

the

near

term

as

central

banks

tighten

policy

amid

slowing

economic

growth.

However,

in

our

view,

valuations

have

become

more

attractive

across

many

market

sectors

during

the

downturn,

which

provides

potential

opportunities

for

selective

investors

focused

on

fundamentals.  

We

believe

this

environment

makes

skilled

active

management

a

critical

tool

for

identifying

risks

and

opportunities,

and

our

investment

teams

will

continue

to

use

fundamental

research

to

identify

securities

that

can

add

value

to

your

portfolio

over

the

long

term. 

Thank

you

for

your

continued

confidence

in

T.

Rowe

Price.

Sincerely,

Robert

Sharps

CEO

and

President

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Management’s

Discussion

of

Fund

Performance

3

INVESTMENT

OBJECTIVE 

The

fund

seeks

long-term

growth

of

capital.

FUND

COMMENTARY

How

did

the

fund

perform

in

the

past 12

months?

The

China

Evolution

Equity

Fund

returned

-40.83%

in

the

12-month

period

ended

October

31,

2022,

and

outperformed

the

MSCI

China

All

Shares

Index

Net,

which

returned

-42.58%.

(Returns

for

the

I

Class

shares

will

vary

due

to

a

different

fee

structure.

Past

performance

cannot

guarantee

future

results.

)

What

factors

influenced

the

fund’s

performance?

Chinese

stocks

faced

significant

pressure

amid

global

recession

fears,

the

country’s

zero-tolerance

approach

to

the

coronavirus,

an

ongoing

property

market

downturn,

and

weak

economic

data.

Foreign

investors’

skepticism

in

China’s

growth

outlook

also

grew

after

President

Xi

Jinping

secured

an

unprecedented

third

term

at

Beijing’s

twice-a-decade

Communist

Party

Congress

and

filled

the

country’s

top

leadership

body

with

close

allies.

Against

this

challenging

backdrop,

stock

selection

in

the

industrials

and

business

services

sector

helped

relative

performance,

led

by

our

holding

in

Yangzijiang

Shipbuilding.

Shares

of

China’s

largest

private

shipbuilder

boosted

returns

as

the

company

recorded

a

high

order

backlog

that

will

fill

its

yards

until

2024

and

secured

a

license

paving

its

entry

into

the

liquefied

natural

gas

(LNG)

carrier

market,

which

is

seeing

growing

demand

for

cleaner

LNG

dual-

fuel

vessels.

(Please

refer

to

the

portfolio

of

investments

for

a

complete

list

of

holdings

and

the

amount

each

represents

in

the

portfolio.)

Stock

selection

in

the

consumer

discretionary

and

health

care

sectors

helped

relative

returns.

In

the

discretionary

sector,

our

position

in

auto

gear

and

shaft

manufacturer

Zhejiang

Shuanghuan

Driveline

added

value

as

increasing

electric

vehicle

sales

spurred

demand

for

the

company’s

high

precision

gears.

In

health

care,

our

holding

in

medical

device

maker

Shandong

Weigao

Group

PERFORMANCE

COMPARISON

Total

Return

Periods

Ended

10/31/22

6

Months

12

Months

China

Evolution

Equity

Fund

–

.

-19.48‌%

-40.83‌%

China

Evolution

Equity

Fund–

.

I  Class

-19.30‌

-40.57‌

MSCI

China

All

Shares

Index

Net

-24.66‌

-42.58‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

4

Medical

Polymer

proved

helpful

as

the

consumable

medical

devices

maker

won

the

bids

in

the

government’s

volume-based

procurement

(VBP)

of

spinal

implants

at

a

price

that

we

believe

indicated

low

risks

of

margin

erosion.

The

VBP

aims

to

lower

the

price

of

medical

consumables.

Conversely,

an

underweight

allocation

to

financials

significantly

detracted

from

relative

performance.

Our

lack

of

exposure

to

the

large,

state-owned

banks

that

outperformed

hurt

relative

returns

given

the

fund’s

focus

on

holding

companies

beyond

the

100

largest

stocks

in

China

in

terms

of

market

capitalization.

Real

estate

stocks

weighed

on

relative

performance

owing

to

adverse

selection.

Country

Garden

Services,

a

property

management

company

linked

to

China’s

largest

developer

Country

Garden,

was

a

sizable

detractor.

Despite

our

belief

in

its

strong

fundamentals,

Country

Garden

Services

shares

fell

along

with

the

broader

industry.

Property-related

names

slumped

as

a

yearslong

debt

crisis

in

China’s

real

estate

sector

led

to

corporate

defaults

and

a

mortgage

boycott

by

some

frustrated

homebuyers

waiting

for

cash-strapped

developers

to

finish

delayed

projects.

How

is

the

fund

positioned?

The

China

Evolution

Equity

Fund

seeks

to

identify

China’s

future

winners

and

niche

market

leaders

that

we

believe

are

overlooked

and

under-owned

by

most

investors.

As

noted

earlier,

the

fund

has

been

designed

to

exclude

from

its

search

the

100

largest

stocks

in

China

in

terms

of

market

capitalization,

and

this

translates

to

a

significant

underweight

allocation

to

areas

dominated

by

mega-cap

companies,

such

as

financials

and

the

internet,

and

relatively

large

allocations

to

the

industrials

and

business

services

and

select

consumer-related

sectors.

In

a

highly

uncertain

macroeconomic

backdrop,

we

sought

to

build

a

more

balanced

portfolio

by

seeking

investment

ideas

in

three

areas.

The

first

category

includes

businesses

that

we

regard

as

the

best

growth

assets

in

China

that

have

been

temporarily

impaired

by

the

zero-COVID

policy

but

face

better

prospects

in

the

next

one

to

two

years.

In

this

category,

we

bought

shares

of

Kanzhun,

an

online

recruitment

platform

that

has

an

innovative

business

model;

hotel

operator

H

World;

and

property

management

company

China

Resources

Mixc

Lifestyle

Services.

Secondly,

we

invested

in

businesses

that

have

distinct

drivers

and

that

are

less

sensitive

to

the

macro

environment.

This

category

includes

electric

vehicle

parts

makers,

solar-related

names,

shipbuilders,

and

oil

services

providers.

We

bought

shares

of

Fuyao

Glass

Industry,

an

auto

glassmaker

that

is

gaining

market

share,

and

started

a

position

in

Jiangsu

GoodWe

Power

Supply

Technology,

a

maker

of

solar

energy

equipment

and

storage

solutions.

In

the

T.

ROWE

PRICE

China

Evolution

Equity

Fund

5

energy

sector,

we

purchased

fracking

equipment

manufacturer

Yantai

Jereh

Oilfield

Services

and

China

Oilfield

Services,

both

of

which

stand

to

benefit

as

China

steps

up

investing

in

nonconventional

oil

and

gas

exploration

to

meet

its

energy

security

demands.

The

third

category

encompasses

value-oriented,

defensive

businesses

that

provided

decent

dividend

yields

and

traded

at

attractive

valuations.

We

started

a

position

in

natural

gas

distributor

China

Resources

Gas

Group,

which

we

view

as

a

bet

on

rising

gas

consumption

in

China

and

a

beneficiary

of

potential

industry

consolidation.

We

added

Tingyi

(Cayman

Island),

a

leading

maker

of

instant

noodles

and

convenience

foods

that

offers

an

attractive

dividend

yield

and

a

strong

margin

improvement

opportunity

as

cost

inflation

recedes.

Notable

sales

included

Guangdong

Kinlong

Hardware

Products,

a

seller

of

architectural

metal

hardware

used

in

homes

and

commercial

spaces,

as

we

believed

that

China’s

property

slump

would

weigh

on

building

products

demand

and

depress

the

company’s

earnings.

We

reduced

our

allocation

to

the

real

estate

sector,

which

had

been

weakened

by

Beijing’s

efforts

to

curb

excessive

borrowing

among

the

country’s

property

developers.

More

recently,

local

governments

across

China

have

rolled

out

homebuying

subsidies,

lower

mortgages,

and

other

measures

to

boost

housing

demand.

We

reduced

our

holding

in

Country

Garden

Services

but

added

to

China

Resources

Mixc

Lifestyle

Services,

which

manages

China’s

largest

portfolio

of

high-end

shopping

malls

and

is

well

positioned

to

benefit

from

consumption

upgrading

among

Chinese

consumers.

SECTOR

DIVERSIFICATION

Percent

of

Net

Assets

4/30/22

10/31/22

Industrials

and

Business

Services

21.2‌%

27.3‌%

Consumer

Discretionary

26.5‌ 

19.3‌ 

Health

Care

7.4‌ 

11.3‌ 

Real

Estate

14.1‌ 

9.5‌ 

Communication

Services

7.1‌ 

7.6‌ 

Consumer

Staples

5.3‌ 

6.1‌ 

Energy

0.0‌ 

4.6‌ 

Information

Technology

7.9‌ 

4.4‌ 

Utilities

2.7‌ 

2.5‌ 

Materials

0.8‌ 

1.7‌ 

Financials

1.9‌ 

0.0‌ 

Other

and

Reserves

5.1‌ 

5.7‌ 

Total

100.0‌%

100.0‌%

Historical

weightings

reflect

current

industry/sector

classifications.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

6

What

is

portfolio

management’s

outlook?

China’s

economy

faces

many

challenges,

but

we

believe

that

promoting

more

sustainable

growth

is

a

government

priority.

We

think

that

Beijing

will

maintain

its

emphasis

on

manufacturing

and

technology,

and

areas

that

stand

to

benefit

from

this

focus,

such

as

industrials

and

business

services,

should

be

fruitful

ground

for

bottom-up,

active

investment

managers.

The

businesses

aligned

with

this

trend

are

mostly

listed

on

domestic

stock

exchanges,

and

we

will

stay

nimble

to

capture

these

opportunities.

The

undemanding

valuations

of

Chinese

equities

compared

with

their

global

counterparts

offer

an

attractive

entry

point

for

long-term

investors.

We

continue

to

identify

sustainable

businesses

with

strong

potential

to

become

future

winners

and

market

leaders.

The

accelerating

shift

toward

electric

vehicles

and

transition

to

renewable

energy

will

be

a

tailwind

for

many

industries.

Supply

chain

realignment

is

an

area

of

interest

as

local

companies

move

up

the

value

chain,

especially

for

semiconductor

and

medical

device

manufacturers.

We

see

opportunities

for

consolidation

in

many

fragmented

industries

in

China,

such

as

hotels

and

shopping

malls,

and

have

identified

companies

that

are

taking

market

share

and

starting

to

lead

the

consolidation.

We

think

that

China’s

property

market

is

stabilizing

and

that

the

worst

of

the

downturn

has

passed

following

the

government’s

support

measures.

China’s

“dynamic

zero-COVID”

approach

remains

a

key

concern

to

the

economy.

Recently,

Beijing

has

fine-tuned

the

related

policies

and

laid

out

more

concrete

steps

for

reopening.

These

signals

bode

well

for

the

stock

market,

but

investors

should

temper

their

expectations

on

how

fast

the

economy

can

improve

in

the

near

term

as

the

policies

are

still

restrictive

by

nature

and

policy

execution

at

the

local

level

may

create

some

volatilities.

Having

said

that,

the

direction

of

travel

is

much

clearer,

and

the

possibility

of

fully

reopening

next

year

looks

much

higher.

This,

together

with

the

supportive

property

measures

we

are

seeing,

may

indicate

that

the

government

remains

focused

on

economic

growth

and

allay

some

of

the

markets’

concerns

of

a

shift

in

policies

following

the

Communist

Party

Congress.

With

better

visibility

of

China’s

exit

from

its

COVID

strategy,

along

with

the

policy

package

to

aid

the

property

sector,

we

expect

domestic

consumption

and

services

to

accelerate

in

2023.

This

will

likely

lead

to

broader

market

leadership,

which

bodes

well

for

bottom-up

investors.

The

views

expressed

reflect

the

opinions

of

T.

Rowe

Price

as

of

the

date

of

this

report

and

are

subject

to

change

based

on

changes

in

market,

economic,

or

other

conditions.

These

views

are

not

intended

to

be

a

forecast

of

future

events

and

are

no

guarantee

of

future

results.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

7

RISKS

OF

INVESTING

IN

GREATER

CHINA

The

Chinese

economy

is

generally

considered

an

emerging

and

volatile

market.

A

small

number

of

companies

represent

a

large

portion

of

the

China

market

as

a

whole,

and

prices

for

securities

of

these

companies

may

be

very

sensitive

to

adverse

political,

economic,

or

regulatory

developments

in

China

and

other

Asian

countries,

and

may

experience

significant

losses

in

such

conditions.

China’s

central

government

has

historically

exercised

substantial

control

over

the

Chinese

economy

through

administrative

regulation

and/or

state

ownership.

RISKS

OF

INTERNATIONAL

INVESTING

Investments

outside

the

U.S.

may

lose

value

because

of

declining

foreign

currencies

or

adverse

political

or

economic

events

overseas,

among

other

things.

Securities

of

non-U.S.

issuers

(including

depositary

receipts

and

other

instruments

that

represent

interests

in

a

non-U.S.

issuer)

tend

to

be

more

volatile

than

U.S.

securities

and

are

subject

to

trading

markets

with

lower

overall

liquidity,

governmental

interference,

and

regulatory

and

accounting

standards

and

settlement

practices

that

differ

from

the

U.S.

The

fund

could

experience

losses

based

solely

on

the

weakness

of

foreign

currencies

in

which

the

fund’s

holdings

are

denominated

versus

the

U.S.

dollar,

and

changes

in

the

exchange

rates

between

such

currencies

and

the

U.S.

dollar.

Risks

can

result

from

differing

regulatory

environments,

less

stringent

investor

protections,

uncertain

tax

laws,

and

higher

transaction

costs

compared

with

U.S.

markets.

Investments

outside

the

U.S.

could

be

subject

to

governmental

actions

such

as

capital

or

currency

controls,

nationalization

of

a

company

or

industry,

expropriation

of

assets,

or

imposition

of

high

taxes.

RISKS

OF

NONDIVERSIFICATION

Because

the

fund

is

nondiversified

and

thus

can

invest

more

of

its

assets

in

a

smaller

number

of

issuers,

it

is

more

exposed

to

the

risks

associated

with

an

individual

issuer

than

a

fund

that

invests

more

broadly

across

many

issuers.

For

example,

poor

performance

by

a

single

large

holding

of

the

fund

would

adversely

affect

the

fund’s

performance

more

than

if

the

fund

were

invested

in

a

larger

number

of

issuers.

For

a

more

thorough

discussion

of

risks,

please

see

the

fund’s

prospectus.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

8

BENCHMARK

INFORMATION

Note:

MSCI

and

its

affiliates

and

third-party

sources

and

providers

(collectively,

“MSCI”)

makes

no

express

or

implied

warranties

or

representations

and

shall

have

no

liability

whatsoever

with

respect

to

any

MSCI

data

contained

herein.

The

MSCI

data

may

not

be

further

redistributed

or

used

as

a

basis

for

other

indices

or

any

securities

or

financial

products.

This

report

is

not

approved,

reviewed,

or

produced

by

MSCI.

Historical

MSCI

data

and

analysis

should

not

be

taken

as

an

indication

or

guarantee

of

any

future

performance

analysis,

forecast

or

prediction.

None

of

the

MSCI

data

is

intended

to

constitute

investment

advice

or

a

recommendation

to

make

(or

refrain

from

making)

any

kind

of

investment

decision

and

may

not

be

relied

on

as

such.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

9

PORTFOLIO

HIGHLIGHTS

TWENTY-FIVE

LARGEST

ISSUERS

Percent

of

Net

Assets

10/31/22

Kanzhun,

China

5.4‌%

Yangzijiang

Shipbuilding

Holdings,

China

4.5‌ 

Shandong

Weigao

Group

Medical

Polymer,

China

3.8‌ 

H

World

Group,

China

3.7‌ 

China

Resources

Mixc

Lifestyle

Services,

China

3.7‌ 

Qingdao

Haier

Biomedical,

China

3.6‌

NARI

Technology,

China

3.6‌

Tsingtao

Brewery,

China

3.1‌

Warom

Technology,

China

3.0‌

Tingyi

Cayman

Islands

Holding,

China

2.9‌

Haier

Smart

Home,

China

2.8‌

Shenzhen

Megmeet

Electrical,

China

2.8‌

China

Resources

Land,

China

2.7‌

Hongfa

Technology,

China

2.7‌

Fuyao

Glass

Industry

Group,

China

2.7‌

GoodWe

Technologies,

China

2.6‌

Zhejiang

Shuanghuan

Driveline,

China

2.5‌

China

Resources

Gas

Group,

China

2.5‌

China

Oilfield

Services,

China

2.4‌

Yantai

Jereh

Oilfield

Services

Group,

China

2.2‌

Focus

Media

Information

Technology,

China

2.1‌

Sino

Biopharmaceutical,

China

2.0‌

ZTO

Express

Cayman,

China

2.0‌

KE

Holdings,

China

2.0‌

Shandong

Pharmaceutical

Glass,

China

1.9‌

Total

73.2‌%

Note:

The

information

shown

does

not

reflect

any

exchange-traded

funds

(ETFs),

cash

reserves,

or

collateral

for

securities

lending

that

may

be

held

in

the

portfolio.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

10

GROWTH

OF

$10,000 

This

chart

shows

the

value

of

a

hypothetical

$10,000

investment

in

the

fund

over

the

past

10

fiscal

year

periods

or

since

inception

(for funds

lacking

10-year

records).

The

result

is

compared

with

benchmarks,

which

include

a

broad-based

market

index

and

may

also

include

a

peer

group

average

or

index.

Market

indexes

do

not

include

expenses,

which

are

deducted

from

fund

returns

as

well

as

mutual fund

averages

and

indexes.

CHINA

EVOLUTION

EQUITY

FUND 

Note:

Performance

for

the

I

Class will

vary

due

to

its differing

fee

structure.

See

the

Average

Annual

Compound

Total

Return

table. 

AVERAGE

ANNUAL

COMPOUND

TOTAL

RETURN

Periods

Ended

10/31/22

1

Year

Since

Inception

12/10/19

China

Evolution

Equity

Fund

–

.

-40.83‌%

1.56‌%

China

Evolution

Equity

Fund–

.

I  Class

-40.57‌

1.96‌

This

table

shows

how

the

fund

would

have

performed

each

year

if

its

actual

(or

cumulative)

returns

for

the

periods

shown

had

been

earned

at

a

constant

rate.

Returns

do

not

reflect

taxes

that

the

shareholder

may

pay

on

fund

distributions

or

the

redemption

of

fund

shares.

Past

performance

cannot

guarantee

future

results.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

11

EXPENSE

RATIO

FUND

EXPENSE

EXAMPLE

As

a

mutual

fund

shareholder,

you

may

incur

two

types

of

costs:

(1)

transaction

costs,

such

as

redemption

fees

or

sales

loads,

and

(2)

ongoing

costs,

including

management

fees,

distribution

and

service

(12b-1)

fees,

and

other

fund

expenses.

The

following

example

is

intended

to

help

you

understand

your

ongoing

costs

(in

dollars)

of

investing

in

the

fund

and

to

compare

these

costs

with

the

ongoing

costs

of

investing

in

other

mutual

funds.

The

example

is

based

on

an

investment

of

$1,000

invested

at

the

beginning

of

the

most

recent

six-month

period

and

held

for

the

entire

period.

Please

note

that

the

fund

has

two

share

classes:

The

original

share

class

(Investor

Class)

charges

no

distribution

and

service

(12b-1)

fee,

and

the

I

Class

shares

are

also

available

to

institutionally

oriented

clients

and

impose

no

12b-1

or

administrative

fee

payment.

Each

share

class

is

presented

separately

in

the

table.

Actual

Expenses

The

first

line

of

the

following

table

(Actual)

provides

information

about

actual

account

values

and

expenses

based

on

the

fund’s

actual

returns.

You

may

use

the

information

on

this

line,

together

with

your

account

balance,

to

estimate

the

expenses

that

you

paid

over

the

period.

Simply

divide

your

account

value

by

$1,000

(for

example,

an

$8,600

account

value

divided

by

$1,000

=

8.6),

then

multiply

the

result

by

the

number

on

the

first

line

under

the

heading

“Expenses

Paid

During

Period”

to

estimate

the

expenses

you

paid

on

your

account

during

this

period.

Hypothetical

Example

for

Comparison

Purposes

The

information

on

the

second

line

of

the

table

(Hypothetical)

is

based

on

hypothetical

account

values

and

expenses

derived

from

the

fund’s

actual

expense

ratio

and

an

assumed

5%

per

year

rate

of

return

before

expenses

(not

the

fund’s

actual

return).

You

may

compare

the

ongoing

costs

of

investing

in

the

fund

with

other

funds

by

contrasting

this

5%

hypothetical

example

and

the

5%

hypothetical

examples

that

appear

in

the

shareholder

reports

of

the

other

funds.

The

hypothetical

account

values

and

expenses

may

not

be

used

to

estimate

the

actual

ending

account

balance

or

expenses

you

paid

for

the

period.

China

Evolution

Equity

Fund

1.45‌%

China

Evolution

Equity

Fund–I

Class

1.28‌ 

The

expense

ratio

shown

is

as

of

the

fund’s

most

recent

prospectus.

This

number

may

vary

from

the

expense

ratio

shown

elsewhere

in

this

report

because

it

is

based

on

a

different

time

period

and,

if

applicable,

includes

acquired

fund

fees

and

expenses

but

does

not

include

fee

or

expense

waivers.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

12

Note:

T.

Rowe

Price

charges

an

annual

account

service

fee

of

$20,

generally

for

accounts

with

less

than

$10,000.

The

fee

is

waived

for

any

investor

whose

T.

Rowe

Price

mutual

fund

accounts

total

$50,000

or

more;

accounts

electing

to

receive

electronic

delivery

of

account

statements,

transaction

confirmations,

prospectuses,

and

shareholder

reports;

or

accounts

of

an

investor

who

is

a

T.

Rowe

Price

Personal

Services

or

Enhanced

Personal

Services

client

(enrollment

in

these

programs

generally

requires

T.

Rowe

Price

assets

of

at

least

$250,000).

This

fee

is

not

included

in

the

accompanying

table.

If

you

are

subject

to

the

fee,

keep

it

in

mind

when

you

are

estimating

the

ongoing

expenses

of

investing

in

the

fund

and

when

comparing

the

expenses

of

this

fund

with

other

funds.

You

should

also

be

aware

that

the

expenses

shown

in

the

table

highlight

only

your

ongoing

costs

and

do

not

reflect

any

transaction

costs,

such

as

redemption

fees

or

sales

loads.

Therefore,

the

second

line

of

the

table

is

useful

in

comparing

ongoing

costs

only

and

will

not

help

you

determine

the

relative

total

costs

of

owning

different

funds.

To

the

extent

a

fund

charges

transaction

costs,

however,

the

total

cost

of

owning

that

fund

is

higher.

CHINA

EVOLUTION

EQUITY

FUND

Beginning

Account

Value

5/1/22

Ending

Account

Value

10/31/22

Expenses

Paid

During

Period*

5/1/22

to

10/31/22

Investor

Class

Actual

$1,000.00

$805.20

$6.37

Hypothetical

(assumes

5%

return

before

expenses)

 1,000.00

  1,018.15

  7.12

I

Class

Actual

  1,000.00

  807.00

  4.74

Hypothetical

(assumes

5%

return

before

expenses)

 1,000.00

  1,019.96

  5.30

*

Expenses

are

equal

to

the

fund’s

annualized

expense

ratio

for

the

6-month

period,

multiplied

by

the

average

account

value

over

the

period,

multiplied

by

the

number

of

days

in

the

most

recent

fiscal

half

year

(184),

and

divided

by

the

days

in

the

year

(365)

to

reflect

the

half-year

period.

The

annualized

expense

ratio

of

the

1

Investor

Class

was

1.40%,

and

the

2

I

Class

was

1.04%.

FUND

EXPENSE

EXAMPLE

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

13

QUARTER-END

RETURNS

Periods

Ended

9/30/22

1

Year

Since

Inception

12/10/19

China

Evolution

Equity

Fund

–

.

-31.89‌%

6.97‌%

China

Evolution

Equity

Fund–

.

I  Class

-31.66‌ 

7.35‌ 

The

fund’s

performance

information

represents

only

past

performance

and

is

not

necessarily

an

indication

of

future

results.

Current

performance

may

be

lower

or

higher

than

the

performance

data

cited.

Share

price,

principal

value,

and

return

will

vary,

and

you

may

have

a

gain

or

loss

when

you

sell

your

shares.

For

the

most

recent

month-end

performance,

please

visit

our

website

(troweprice.com)

or

contact

a

T.

Rowe

Price

representative

at

1

-

800

-

225

-

5132

or,

for

2

I

Class

shares,

1-800-638-8790

.

This

table

provides

returns

through

the

most

recent

calendar

quarter-end

rather

than

through

the

end

of

the

fund’s

fiscal

period.

It

shows

how

the

fund

would

have

performed

each

year

if

its

actual

(or

cumulative)

returns

for

the

periods

shown

had

been

earned

at

a

constant

rate.

Average

annual

total

return

figures

include

changes

in

principal

value,

reinvested

dividends,

and

capital

gain

distributions.

Returns

do

not

reflect

taxes

that

the

shareholder

may

pay

on

fund

distributions

or

the

redemption

of

fund

shares.

When

assessing

performance,

investors

should

consider

both

short-

and

long-term

returns.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Financial

Highlights

14

For

a

share

outstanding

throughout

each

period

The

accompanying

notes

are

an

integral

part

of

these

financial

statements.

Investor

Class

(1)

..

Year

..

..

Ended

.

12/10/19

(1)

Through

10/31/20

10/31/22

10/31/21

NET

ASSET

VALUE

Beginning

of

period

$

17.40‌

$

14.95‌

$

10.00‌

Investment

activities

Net

investment

loss

(2)(3)

(0.01‌)

(0.03‌)

(—‌)

(4)

Net

realized

and

unrealized

gain/loss

(6.65‌)

2.73‌

4.95‌

Total

from

investment

activities

(6.66‌)

2.70‌

4.95‌

Distributions

Net

realized

gain

(1.07‌)

(0.25‌)

—‌

NET

ASSET

VALUE

End

of

period

$

9.67‌

$

17.40‌

$

14.95‌

Ratios/Supplemental

Data

Total

return

(3)(5)

(40.83‌)%

18.22‌%

49.50‌%

Ratios

to

average

net

assets:

(3)

Gross

expenses

before

waivers/payments

by

Price

Associates

1.94‌%

1.45‌%

2.49‌%

(6)

Net

expenses

after

waivers/payments

by

Price

Associates

1.40‌%

1.40‌%

1.43‌%

(6)

Net

investment

loss

(0.08‌)%

(0.19‌)%

(0.03‌)%

(6)

Portfolio

turnover

rate

62.2‌%

106.6‌%

60.6‌%

Net

assets,

end

of

period

(in

thousands)

$17,584

$63,037

$40,838

0‌%

0‌%

0‌%

(1)

Inception

date

(2)

Per

share

amounts

calculated

using

average

shares

outstanding

method.

(3)

See

Note

6

for

details

of

expense-related

arrangements

with

Price

Associates.

(4)

Amounts

round

to

less

than

$0.01

per

share.

(5)

Total

return

reflects

the

rate

that

an

investor

would

have

earned

on

an

investment

in

the

fund

during

each

period,

assuming

reinvestment

of

all

distributions,

and

payment

of

no

redemption

or

account

fees,

if

applicable.

Total

return

is

not

annualized

for

periods

less

than

one

year.

(6)

Annualized

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Financial

Highlights

15

For

a

share

outstanding

throughout

each

period

The

accompanying

notes

are

an

integral

part

of

these

financial

statements.

I

Class

(1)

..

Year

..

..

Ended

.

12/10/19

(1)

Through

10/31/20

10/31/22

10/31/21

NET

ASSET

VALUE

Beginning

of

period

$

17.52‌

$

15.00‌

$

10.00‌

Investment

activities

Net

investment

income

(2)(3)

0.09‌

0.09‌

0.05‌

Net

realized

and

unrealized

gain/loss

(6.64‌)

2.68‌

4.95‌

Total

from

investment

activities

(6.55‌)

2.77‌

5.00‌

Distributions

Net

realized

gain

(1.35‌)

(0.25‌)

—‌

NET

ASSET

VALUE

End

of

period

$

9.62‌

$

17.52‌

$

15.00‌

Ratios/Supplemental

Data

Total

return

(3)(4)

(40.57‌)%

18.63‌%

50.00‌%

Ratios

to

average

net

assets:

(3)

Gross

expenses

before

waivers/payments

by

Price

Associates

1.53‌%

1.28‌%

2.48‌%

(5)

Net

expenses

after

waivers/payments

by

Price

Associates

1.04‌%

1.04‌%

1.08‌%

(5)

Net

investment

income

0.70‌%

0.47‌%

0.45‌%

(5)

Portfolio

turnover

rate

62.2‌%

106.6‌%

60.6‌%

Net

assets,

end

of

period

(in

thousands)

$30,679

$22,749

$2,912

0‌%

0‌%

0‌%

(1)

Inception

date

(2)

Per

share

amounts

calculated

using

average

shares

outstanding

method.

(3)

See

Note

6

for

details

of

expense-related

arrangements

with

Price

Associates.

(4)

Total

return

reflects

the

rate

that

an

investor

would

have

earned

on

an

investment

in

the

fund

during

each

period,

assuming

reinvestment

of

all

distributions,

and

payment

of

no

redemption

or

account

fees,

if

applicable.

Total

return

is

not

annualized

for

periods

less

than

one

year.

(5)

Annualized

T.

ROWE

PRICE

China

Evolution

Equity

Fund

October

31,

2022

16

Portfolio

of

Investments

‡

Shares

$

Value

(

Cost

and

value

in

$000s)

‡

CHINA

92.5%

Common

Stocks

48.9%

BOE

Varitronix

(HKD) 

511,000‌

758‌

China

Resources

Gas

Group

(HKD) 

462,900‌

1,186‌

China

Resources

Land

(HKD) 

420,000‌

1,314‌

China

Resources

Mixc

Lifestyle

Services

(HKD) 

610,230‌

1,787‌

Country

Garden

Services

Holdings

(HKD) 

635,000‌

555‌

H

World

Group

(HKD) 

655,200‌

1,788‌

Haier

Smart

Home,

Class

H

(HKD) 

549,200‌

1,375‌

Kanzhun,

ADR

(USD)  (1)

240,272‌

2,626‌

KE

Holdings,

ADR

(USD)  (1)

93,189‌

949‌

Li

Auto,

Class

A

(HKD)  (1)(2)

94,600‌

650‌

Li

Ning

(HKD) 

137,500‌

711‌

Shandong

Weigao

Group

Medical

Polymer,

Class

H

(HKD) 

1,321,200‌

1,820‌

Sino

Biopharmaceutical

(HKD) 

2,011,500‌

976‌

Sunny

Optical

Technology

Group

(HKD) 

16,200‌

140‌

Tingyi

Cayman

Islands

Holding

(HKD) 

910,000‌

1,422‌

Tsingtao

Brewery,

Class

H

(HKD) 

216,000‌

1,512‌

Yangzijiang

Shipbuilding

Holdings

(SGD) 

2,581,600‌

2,188‌

Yum

China

Holdings

(USD) 

22,000‌

910‌

ZTO

Express

Cayman

(HKD) 

55,950‌

952‌

23,619‌

Common

Stocks

-

China

A

Shares

43.6%

China

Oilfield

Services,

A

Shares

(CNH) 

498,601‌

1,147‌

Focus

Media

Information

Technology,

A

Shares

(CNH) 

1,661,780‌

1,022‌

Fuyao

Glass

Industry

Group,

A

Shares

(CNH) 

280,544‌

1,284‌

GoodWe

Technologies,

A

Shares

(CNH) 

26,768‌

1,230‌

Hichain

Logistics,

A

Shares  (3)

167,540‌

605‌

Hongfa

Technology,

A

Shares

(CNH) 

278,447‌

1,311‌

Hoymiles

Power

Electronics,

A

Shares  (3)

6,842‌

819‌

Jason

Furniture

Hangzhou,

A

Shares

(CNH) 

205,257‌

851‌

NARI

Technology,

A

Shares

(CNH) 

514,804‌

1,727‌

Oppein

Home

Group,

A

Shares

(CNH) 

45,800‌

511‌

Qingdao

Haier

Biomedical,

A

Shares  (3)

164,830‌

1,743‌

Shandong

Pharmaceutical

Glass,

A

Shares

(CNH) 

248,400‌

939‌

Shenzhen

Inovance

Technology,

A

Shares

(CNH) 

22,900‌

210‌

Shenzhen

Megmeet

Electrical,

A

Shares

(CNH) 

386,680‌

1,344‌

Wanhua

Chemical

Group,

A

Shares

(CNH) 

76,376‌

842‌

Warom

Technology,

A

Shares  (3)

478,110‌

1,468‌

Yantai

Jereh

Oilfield

Services

Group,

A

Shares

(CNH) 

263,000‌

1,084‌

YTO

Express

Group,

A

Shares

(CNH) 

315,500‌

816‌

Zhejiang

HangKe

Technology,

A

Shares

(CNH) 

67,484‌

463‌

Zhejiang

Shuanghuan

Driveline,

A

Shares  (3)

314,100‌

1,224‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

16

T.

ROWE

PRICE

China

Evolution

Equity

Fund

17

Shares

$

Value

(Cost

and

value

in

$000s)

Zhongji

Innolight,

A

Shares

(CNH) 

98,919‌

397‌

21,037‌

Total

China

(Cost

$60,108

)

44,656‌

HONG

KONG

0.1%

Common

Stocks

0.1%

Impro

Precision

Industries 

206,000‌

53‌

Total

Hong

Kong

(Cost

$72

)

53‌

TAIWAN

1.6%

Common

Stocks

1.6%

Chroma

ATE 

148,000‌

808‌

Total

Taiwan

(Cost

$967

)

808‌

SHORT-TERM

INVESTMENTS

3.0%

Money

Market

Funds

3.0%

T.

Rowe

Price

Government

Reserve

Fund,

3.21%  (4)(5)

1,429,565‌

1,430‌

Total

Short-Term

Investments

(Cost

$1,430)

1,430‌

SECURITIES

LENDING

COLLATERAL

1.3%

INVESTMENTS

IN

A

POOLED

ACCOUNT

THROUGH

SECURITIES

LENDING

PROGRAM

WITH

JPMORGAN

CHASE

BANK

1.3%

Money

Market

Funds

1.3%

T.

Rowe

Price

Government

Reserve

Fund,

3.21%  (4)(5)

613,008‌

613‌

Total

Investments

in

a

Pooled

Account

through

Securities

Lending

Program

with

JPMorgan

Chase

Bank

613‌

Total

Securities

Lending

Collateral

(Cost

$613)

613‌

Total

Investments

in

Securities

98.5%

of

Net

Assets

(Cost

$63,190)

$

47,560‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

18

‡

Country

classifications

are

generally

based

on

MSCI

categories

or

another

unaffiliated

third

party

data

provider;

Shares

are

denominated

in

the

currency

of

the

country

presented

unless

otherwise

noted.

(1)

Non-income

producing

(2)

See

Note

3

.

All

or

a

portion

of

this

security

is

on

loan

at

October

31,

2022.

(3)

See

Note

3.

China

A

shares

held

through

the

QFII

are

subject

to

certain

restrictions.

(4)

Seven-day

yield

(5)

Affiliated

Companies

ADR

American

Depositary

Receipts

CNH

Offshore

China

Renminbi

HKD

Hong

Kong

Dollar

SGD

Singapore

Dollar

USD

U.S.

Dollar

T.

ROWE

PRICE

China

Evolution

Equity

Fund

19

The

accompanying

notes

are

an

integral

part

of

these

financial

statements.

AFFILIATED

COMPANIES

($000s)

The

fund

may

invest

in

certain

securities

that

are

considered

affiliated

companies.

As

defined

by

the

1940

Act,

an

affiliated

company

is

one

in

which

the

fund

owns

5%

or

more

of

the

outstanding

voting

securities,

or

a

company

that

is

under

common

ownership

or

control.

The

following

securities

were

considered

affiliated

companies

for

all

or

some

portion

of

the

year

ended

October

31,

2022.

Net

realized

gain

(loss),

investment

income,

change

in

net

unrealized

gain/loss,

and

purchase

and

sales

cost

reflect

all

activity

for

the

period

then

ended.

Affiliate

Net

Realized

Gain

(Loss)

Change

in

Net

Unrealized

Gain/Loss

Investment

Income

T.

Rowe

Price

Government

Reserve

Fund,

3.21%

$

—‌

$

—‌

$

21‌++

Totals

$

—‌#

$

—‌

$

21‌+

Supplementary

Investment

Schedule

Affiliate

Value

10/31/21

Purchase

Cost

Sales

Cost

Value

10/31/22

T.

Rowe

Price

Government

Reserve

Fund,

3.21%

$

4,110‌

 ¤

  ¤

$

2,043‌

Total

$

2,043‌^

#

Capital

gain

distributions

from

underlying

Price

funds

represented

$0

of

the

net

realized

gain

(loss).

++

Excludes

earnings

on

securities

lending

collateral,

which

are

subject

to

rebates

and

fees

as

described

in

Note

3

.

+

Investment

income

comprised

$21

of

dividend

income

and

$0

of

interest

income.

¤

Purchase

and

sale

information

not

shown

for

cash

management

funds.

^

The

cost

basis

of

investments

in

affiliated

companies

was

$2,043.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

October

31,

2022

Statement

of

Assets

and

Liabilities

20

($000s,

except

shares

and

per

share

amounts)

The

accompanying

notes

are

an

integral

part

of

these

financial

statements.

t

Assets

Investments

in

securities,

at

value

(cost

$63,190)

$

47,560‌

Foreign

currency

(cost

$1,584)

1,500‌

Receivable

for

investment

securities

sold

483‌

Receivable

for

shares

sold

58‌

Dividends

receivable

15‌

Due

from

affiliates

11‌

Other

assets

28‌

Total

assets

49,655‌

Liabilities

Payable

for

shares

redeemed

698‌

Obligation

to

return

securities

lending

collateral

613‌

Investment

management

fees

payable

47‌

Other

liabilities

34‌

Total

liabilities

1,392‌

NET

ASSETS

$

48,263‌

Net

Assets

Consist

of:

Total

distributable

earnings

(loss)

$

(27,402‌)

Paid-in

capital

applicable

to

5,006,963

shares

of

$0.01

par

value

capital

stock

outstanding;

18,000,000,000

shares

of

the

Corporation

authorized

75,665‌

NET

ASSETS

$

48,263‌

NET

ASSET

VALUE

PER

SHARE

Investor

Class

($17,584,058

/

1,817,844

shares

outstanding)

$

9.67‌

I

Class

($30,678,525

/

3,189,119

shares

outstanding)

$

9.62‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Statement

of

Operations

21

($000s)

Year

Ended

10/31/22

Investment

Income

(Loss)

Income

Dividend

(net

of

foreign

taxes

of

$50)

$

1,039‌

Securities

lending

1‌

Total

income

1,040‌

Expenses

Investment

management

673‌

Shareholder

servicing

Investor

Class

$

146‌

I

Class

7‌

153‌

Prospectus

and

shareholder

reports

Investor

Class

14‌

I

Class

3‌

17‌

Custody

and

accounting

202‌

Registration

58‌

Legal

and

audit

43‌

Miscellaneous

41‌

Waived

/

paid

by

Price

Associates

(351‌)

Total

expenses

836‌

Net

investment

income

204‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Statement

of

Operations

22

($000s)

The

accompanying

notes

are

an

integral

part

of

these

financial

statements.

Year

Ended

10/31/22

Realized

and

Unrealized

Gain

/

Loss

–

Net

realized

gain

(loss)

Securities

(10,794‌)

Foreign

currency

transactions

(63‌)

Net

realized

loss

(10,857‌)

Change

in

net

unrealized

gain

/

loss

Securities

(22,992‌)

Other

assets

and

liabilities

denominated

in

foreign

currencies

(92‌)

Change

in

net

unrealized

gain

/

loss

(23,084‌)

Net

realized

and

unrealized

gain

/

loss

(33,941‌)

DECREASE

IN

NET

ASSETS

FROM

OPERATIONS

$

(33,737‌)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

Statement

of

Changes

in

Net

Assets

23

($000s)

The

accompanying

notes

are

an

integral

part

of

these

financial

statements.

Year

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Ended

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

10/31/22

10/31/21

Increase

(Decrease)

in

Net

Assets

Operations

Net

investment

income

(loss)

$

204‌

$

(97‌)

Net

realized

gain

(loss)

(10,857‌)

5,486‌

Change

in

net

unrealized

gain

/

loss

(23,084‌)

1,396‌

Increase

(decrease)

in

net

assets

from

operations

(33,737‌)

6,785‌

Distributions

to

shareholders

Net

earnings

Investor

Class

(3,459‌)

(839‌)

I

Class

(1,920‌)

(85‌)

Decrease

in

net

assets

from

distributions

(5,379‌)

(924‌)

Capital

share

transactions

*

Shares

sold

Investor

Class

16,014‌

124,673‌

I

Class

36,784‌

29,237‌

Distributions

reinvested

Investor

Class

3,349‌

660‌

I

Class

1,844‌

78‌

Shares

redeemed

Investor

Class

(45,696‌)

(109,536‌)

I

Class

(10,702‌)

(8,937‌)

Increase

in

net

assets

from

capital

share

transactions

1,593‌

36,175‌

Net

Assets

Increase

(decrease)

during

period

(37,523‌)

42,036‌

Beginning

of

period

85,786‌

43,750‌

End

of

period

$

48,263‌

$

85,786‌

*Share

information

(000s)

Shares

sold

Investor

Class

1,115‌

6,971‌

I

Class

2,623‌

1,591‌

Distributions

reinvested

Investor

Class

203‌

42‌

I

Class

113‌

5‌

Shares

redeemed

Investor

Class

(3,122‌)

(6,122‌)

I

Class

(845‌)

(492‌)

Increase

in

shares

outstanding

87‌

1,995‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

NOTES

TO

FINANCIAL

STATEMENTS

24

T.

Rowe

Price

International

Funds,

Inc.

(the

corporation) is

registered

under

the

Investment

Company

Act

of

1940

(the

1940

Act).

The

China

Evolution

Equity

Fund

(the

fund)

is a

nondiversified,

open-end

management

investment

company

established

by

the

corporation. The

fund

seeks

long-term

growth

of

capital.

The

fund

has

two classes

of

shares:

the

China

Evolution

Equity

Fund

(Investor

Class)

and

the

China

Evolution

Equity

Fund–I

Class

(I

Class).

I

Class

shares

require

a

$500,000

initial

investment

minimum,

although

the

minimum

generally

is

waived

or

reduced

for

financial

intermediaries,

eligible

retirement

plans,

and

certain

other

accounts.

Prior

to

November

15,

2021,

the

initial

investment

minimum

was

$1

million

and

was

generally

waived

for

financial

intermediaries,

eligible

retirement

plans,

and

other

certain

accounts.

As

a

result

of

the

reduction

in

the

I

Class

minimum,

certain

assets

transferred

from

the

Investor

Class

to

the

I

Class.

This

transfer

of

shares

from

Investor

Class

to

I

Class

is

reflected

in

the

Statement

of

Changes

in

Net

Assets

within

the

Capital

shares

transactions

as

Shares

redeemed

and

Shares

sold,

respectively. Each

class

has

exclusive

voting

rights

on

matters

related

solely

to

that

class;

separate

voting

rights

on

matters

that

relate

to

both

classes;

and,

in

all

other

respects,

the

same

rights

and

obligations

as

the

other

class.

NOTE

1

-

SIGNIFICANT

ACCOUNTING

POLICIES 

Basis

of

Preparation

 The fund

is

an

investment

company

and

follows

accounting

and

reporting

guidance

in

the

Financial

Accounting

Standards

Board

(FASB)

Accounting

Standards

Codification

Topic

946

(ASC

946).

The

accompanying

financial

statements

were

prepared

in

accordance

with

accounting

principles

generally

accepted

in

the

United

States

of

America

(GAAP),

including,

but

not

limited

to,

ASC

946.

GAAP

requires

the

use

of

estimates

made

by

management.

Management

believes

that

estimates

and

valuations

are

appropriate;

however,

actual

results

may

differ

from

those

estimates,

and

the

valuations

reflected

in

the

accompanying

financial

statements

may

differ

from

the

value

ultimately

realized

upon

sale

or

maturity.

Investment

Transactions,

Investment

Income,

and

Distributions

Investment

transactions

are

accounted

for

on

the

trade

date

basis.

Income

and

expenses

are

recorded

on

the

accrual

basis.

Realized

gains

and

losses

are

reported

on

the

identified

cost

basis.

Income

tax-related

interest

and

penalties,

if

incurred,

are

recorded

as

income

tax

expense.

Dividends

received

from

mutual

fund

investments

are

reflected

as

dividend

income;

capital

gain

distributions

are

reflected

as

realized

gain/loss.

Dividend

income

and

capital

gain

distributions

are

recorded

on

the

ex-dividend

date.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

25

Non-cash

dividends,

if

any,

are

recorded

at

the

fair

market

value

of

the

asset

received.

Proceeds

from

litigation

payments,

if

any,

are

included

in

net

realized

gain

(loss)

from

securities.

Distributions

to

shareholders

are

recorded

on

the

ex-dividend

date.

Income

distributions,

if

any,

are

declared

and

paid

by

each

class annually.

A

capital

gain

distribution,

if

any, may

also

be

declared

and

paid

by

the

fund

annually.

Currency

Translation

 Assets,

including

investments,

and

liabilities

denominated

in

foreign

currencies

are

translated

into

U.S.

dollar

values

each

day

at

the

prevailing

exchange

rate,

using

the

mean

of

the

bid

and

asked

prices

of

such

currencies

against

U.S.

dollars

as

provided

by

an

outside

pricing

service.

Purchases

and

sales

of

securities,

income,

and

expenses

are

translated

into

U.S.

dollars

at

the

prevailing

exchange

rate

on

the

respective

date

of

such

transaction.

The

effect

of

changes

in

foreign

currency

exchange

rates

on

realized

and

unrealized

security

gains

and

losses

is

not

bifurcated

from

the

portion

attributable

to

changes

in

market

prices.

Class

Accounting

 Shareholder

servicing,

prospectus,

and

shareholder

report

expenses

incurred

by

each

class

are

charged

directly

to

the

class

to

which

they

relate.

Expenses

common

to all classes,

investment

income,

and

realized

and

unrealized

gains

and

losses

are

allocated

to

the

classes

based

upon

the

relative

daily

net

assets

of

each

class.

Capital

Transactions

 Each

investor’s

interest

in

the

net

assets

of the

fund

is

represented

by

fund

shares. The

fund’s

net

asset

value

(NAV)

per

share

is

computed

at

the

close

of

the

New

York

Stock

Exchange

(NYSE),

normally

4

p.m.

ET,

each

day

the

NYSE

is

open

for

business.

However,

the

NAV

per

share

may

be

calculated

at

a

time

other

than

the

normal

close

of

the

NYSE

if

trading

on

the

NYSE

is

restricted,

if

the

NYSE

closes

earlier,

or

as

may

be

permitted

by

the

SEC.

Purchases

and

redemptions

of

fund

shares

are

transacted

at

the

next-computed

NAV

per

share,

after

receipt

of

the

transaction

order

by

T.

Rowe

Price

Associates,

Inc.,

or

its

agents.

New

Accounting

Guidance

 In

June

2022,

the

FASB

issued

Accounting

Standards

Update

(ASU),

ASU

2022-03,

Fair

Value

Measurement

(Topic

820)

–

Fair

Value

Measurement

of

Equity

Securities

Subject

to

Contractual

Sale

Restrictions,

which

clarifies

that

a

contractual

restriction

on

the

sale

of

an

equity

security

is

not

considered

part

of

the

unit

of

account

of

the

equity

security

and,

therefore,

is

not

considered

in

measuring

fair

value.

The

amendments

under

this

ASU

are

effective

for

fiscal

years

beginning

after

December

15,

2023;

however,

early

adoption

is

permitted.

Management

expects

that

the

adoption

of

the

guidance

will

not

have

a

material

impact

on

the fund's

financial statements.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

26

Indemnification

 In

the

normal

course

of

business, the

fund

may

provide

indemnification

in

connection

with

its

officers

and

directors,

service

providers,

and/or

private

company

investments. The

fund’s

maximum

exposure

under

these

arrangements

is

unknown;

however,

the

risk

of

material

loss

is

currently

considered

to

be

remote.

NOTE

2

-

VALUATION 

Fair

Value

  The

fund’s

financial

instruments

are

valued

at

the

close

of

the

NYSE

and

are

reported

at

fair

value,

which

GAAP

defines

as

the

price

that

would

be

received

to

sell

an

asset

or

paid

to

transfer

a

liability

in

an

orderly

transaction

between

market

participants

at

the

measurement

date. The fund’s

Board

of

Directors

(the

Board)

has

designated

T.

Rowe

Price

Associates,

Inc.

as

the

fund’s

valuation

designee

(Valuation

Designee).

Subject

to

oversight

by

the

Board,

the

Valuation

Designee

performs

the

following

functions

in

performing

fair

value

determinations:

assesses

and

manages

valuation

risks;

establishes

and

applies

fair

value

methodologies;

tests

fair

value

methodologies;

and

evaluates

pricing

vendors

and

pricing

agents.

The

duties

and

responsibilities

of

the

Valuation

Designee

are

performed

by

its

Valuation

Committee. The

Valuation

Designee provides

periodic

reporting

to

the

Board

on

valuation

matters.

Various

valuation

techniques

and

inputs

are

used

to

determine

the

fair

value

of

financial

instruments.

GAAP

establishes

the

following

fair

value

hierarchy

that

categorizes

the

inputs

used

to

measure

fair

value:

Level

1

–

quoted

prices

(unadjusted)

in

active

markets

for

identical

financial

instruments

that

the

fund

can

access

at

the

reporting

date

Level

2

–

inputs

other

than

Level

1

quoted

prices

that

are

observable,

either

directly

or

indirectly

(including,

but

not

limited

to,

quoted

prices

for

similar

financial

instruments

in

active

markets,

quoted

prices

for

identical

or

similar

financial

instruments

in

inactive

markets,

interest

rates

and

yield

curves,

implied

volatilities,

and

credit

spreads)

Level

3

–

unobservable

inputs

(including

the Valuation

Designee’s assumptions

in

determining

fair

value)

Observable

inputs

are

developed

using

market

data,

such

as

publicly

available

information

about

actual

events

or

transactions,

and

reflect

the

assumptions

that

market

participants

would

use

to

price

the

financial

instrument.

Unobservable

inputs

are

those

for

which

market

data

are

not

available

and

are

developed

using

the

best

information

available

about

the

assumptions

that

market

participants

would

use

to

price

the

financial

instrument.

GAAP

requires

valuation

techniques

to

maximize

the

use

of

relevant

T.

ROWE

PRICE

China

Evolution

Equity

Fund

27

observable

inputs

and

minimize

the

use

of

unobservable

inputs.

When

multiple

inputs

are

used

to

derive

fair

value,

the

financial

instrument

is

assigned

to

the

level

within

the

fair

value

hierarchy

based

on

the

lowest-level

input

that

is

significant

to

the

fair

value

of

the

financial

instrument.

Input

levels

are

not

necessarily

an

indication

of

the

risk

or

liquidity

associated

with

financial

instruments

at

that

level

but

rather

the

degree

of

judgment

used

in

determining

those

values.

Valuation

Techniques 

Equity

securities,

including

exchange-traded

funds, listed

or

regularly

traded

on

a

securities

exchange

or

in

the

over-the-counter

(OTC)

market

are

valued

at

the

last

quoted

sale

price

or,

for

certain

markets,

the

official

closing

price

at

the

time

the

valuations

are

made.

OTC

Bulletin

Board

securities

are

valued

at

the

mean

of

the

closing

bid

and

asked

prices.

A

security

that

is

listed

or

traded

on

more

than

one

exchange

is

valued

at

the

quotation

on

the

exchange

determined

to

be

the

primary

market

for

such

security.

Listed

securities

not

traded

on

a

particular

day

are

valued

at

the

mean

of

the

closing

bid

and

asked

prices

for

domestic

securities

and

the

last

quoted

sale

or

closing

price

for

international

securities.

The

last

quoted

prices

of

non-U.S.

equity

securities

may

be

adjusted

to

reflect

the

fair

value

of

such

securities

at

the

close

of

the

NYSE,

if

the Valuation

Designee

determines

that

developments

between

the

close

of

a

foreign

market

and

the

close

of

the

NYSE

will

affect

the

value

of

some

or

all

of the

fund’s

portfolio

securities.

Each

business

day,

the

Valuation

Designee uses

information

from

outside

pricing

services

to

evaluate

and,

if

appropriate,

decide whether

it

is

necessary

to

adjust

quoted

prices

to

reflect

fair

value

by

reviewing

a

variety

of

factors,

including

developments

in

foreign

markets,

the

performance

of

U.S.

securities

markets,

and

the

performance

of

instruments

trading

in

U.S.

markets

that

represent

foreign

securities

and

baskets

of

foreign

securities. The Valuation

Designee

uses

outside

pricing

services

to

provide

it

with

quoted

prices

and

information

to

evaluate

or

adjust

those

prices.

The Valuation

Designee

cannot

predict

how

often

it

will

use

quoted

prices

and

how

often

it

will

determine

it

necessary

to

adjust

those

prices

to

reflect

fair

value.

Investments

in

mutual

funds

are

valued

at

the

mutual

fund’s

closing

NAV

per

share

on

the

day

of

valuation.

Assets

and

liabilities

other

than

financial

instruments,

including

short-term

receivables

and

payables,

are

carried

at

cost,

or

estimated

realizable

value,

if

less,

which

approximates

fair

value. 

Investments

for

which

market

quotations are

not

readily

available

or

deemed

unreliable

are

valued

at

fair

value

as

determined

in

good

faith

by

the

Valuation

Designee.

The

Valuation

Designee

has

adopted

methodologies

for

determining

the

fair

value

of

investments

for

which

market

quotations

are

not

readily

available

or

deemed

unreliable,

including

the

use

of

other

pricing

sources.

Factors

used

in

determining

fair

value

vary

T.

ROWE

PRICE

China

Evolution

Equity

Fund

28

by

type

of

investment

and

may

include

market

or

investment

specific

considerations.

The

Valuation

Designee typically

will

afford

greatest

weight

to

actual

prices

in

arm’s

length

transactions,

to

the

extent

they

represent

orderly

transactions

between

market

participants,

transaction

information

can

be

reliably

obtained,

and

prices

are

deemed

representative

of

fair

value.

However,

the

Valuation

Designee may

also

consider

other

valuation

methods

such

as

market-based

valuation

multiples;

a

discount

or

premium

from

market

value

of

a

similar,

freely

traded

security

of

the

same

issuer;

discounted

cash

flows;

yield

to

maturity;

or

some

combination.

Fair

value

determinations

are

reviewed

on

a

regular

basis.

Because

any

fair

value

determination

involves

a

significant

amount

of

judgment,

there

is

a

degree

of

subjectivity

inherent

in

such

pricing

decisions. Fair

value

prices

determined

by

the

Valuation

Designee could

differ

from

those

of

other

market

participants,

and

it

is

possible

that

the

fair

value

determined

for

a

security

may

be

materially

different

from

the

value

that

could

be

realized

upon

the

sale

of

that

security.

Valuation

Inputs

  The

following

table

summarizes

the

fund’s

financial

instruments,

based

on

the

inputs

used

to

determine

their

fair

values

on

October

31,

2022

(for

further

detail

by

category,

please

refer

to

the

accompanying

Portfolio

of

Investments):

NOTE

3

-

OTHER

INVESTMENT

TRANSACTIONS 

Consistent

with

its

investment

objective,

the

fund

engages

in

the

following

practices

to

manage

exposure

to

certain

risks

and/or

to

enhance

performance.

The

investment

objective,

policies,

program,

and

risk

factors

of

the

fund

are

described

more

fully

in

the

fund’s

prospectus

and

Statement

of

Additional

Information. 

Emerging

and

Frontier

Markets

 The fund

invests,

either

directly

or

through

investments

in

other

T.

Rowe

Price

funds,

in

securities

of

companies

located

in,

issued

by

governments

of,

or

denominated

in

or

linked

to

the

currencies

of

emerging

and

frontier

market

countries.

Emerging

markets,

and

to

a

greater

extent

frontier

($000s)

Level

1

Level

2

Level

3

Total

Value

Assets

Common

Stocks

$

4,485

‌

$

41,032

‌

$

—

‌

$

45,517

‌

Short-Term

Investments

1,430

‌

—

‌

—

‌

1,430

‌

Securities

Lending

Collateral

613

‌

—

‌

—

‌

613

‌

Total

$

6,528

‌

$

41,032

‌

$

—

‌

$

47,560

‌

T.

ROWE

PRICE

China

Evolution

Equity

Fund

29

markets, tend

to

have

economic

structures

that

are

less

diverse

and

mature,

less

developed

legal

and

regulatory

regimes,

and

political

systems

that

are

less

stable,

than

those

of

developed

countries.

These

markets

may

be

subject

to

greater

political,

economic,

and

social

uncertainty

and

differing

accounting

standards

and

regulatory

environments

that

may

potentially

impact

the

fund’s

ability

to

buy

or

sell

certain

securities

or

repatriate

proceeds

to

U.S.

dollars.

Emerging

markets

securities

exchanges

are

more

likely

to

experience

delays

with

the

clearing

and

settling

of

trades,

as

well

as

the

custody

of

holdings

by

local

banks,

agents,

and

depositories.

Such

securities

are

often

subject

to

greater

price

volatility,

less

liquidity,

and

higher

rates

of

inflation

than

U.S.

securities.

Investing

in

frontier

markets

is

typically

significantly

riskier

than

investing

in

other

countries,

including

emerging

markets.

China

A

Shares

 The

fund

invests

in

certain

Chinese

equity

securities

(A

shares)

that

have

limited

availability

to

investors

outside

of

China.

The

fund

gains

access

to

the

A

share

market

through

the

Shanghai-Hong

Kong

Stock

Connect

program

(Shanghai

Stock

Connect),

through

the

Shenzhen-Hong

Kong

Stock

Connect

program

(Shenzhen

Stock

Connect),

or

through

a

wholly

owned

subsidiary

of

Price

Associates,

which

serves

as

the

registered

Qualified

Foreign

Institutional

Investor

(QFII)

for

all

participating

T.

Rowe

Price-sponsored

products

(each

a

participating

account).

Related

to

A

shares

held

through

the

QFII,

investment

decisions

are

specific

to

each

participating

account,

and

each

account

bears

the

economic

consequences

of

its

holdings

and

transactions

in

A

shares.

Further,

the

fund’s

ability

to

repatriate

cash

associated

with

its

A

shares

held

through

the

QFII

is

subject

to

certain

restrictions

and

administrative

processes

involving

the

Chinese

government;

consequently,

the

fund

may

experience

substantial

delays

in

gaining

access

to

its

assets

or

incur

a

loss

of

value

in

the

event

of

noncompliance

with

governmental

requirements.

A

shares

acquired

through

the

QFII

are

valued

using

the

onshore

renminbi

exchange

rate

(CNY),

and

those

acquired

through

the

Shanghai

Stock

Connect

and

the

Shenzhen

Stock

Connect

are

valued

using

the

offshore

renminbi

exchange

rate

(CNH).

CNY

and

CNH

exchange

rates

may

differ;

accordingly,

A

shares

of

the

same

issue

purchased

through

different

channels

may

not

have

the

same

U.S.

dollar

value.

Generally,

the

fund

is

not

subject

to

capital

gains

tax

in

China

related

to

its

A

share

investments

through

the

QFII

(pursuant

to

a

temporary

exemption

from

tax

on

gains

derived

from

the

sale

or

disposition

of

equity

investments,

including

A

shares,

via

a

QFII).

Securities

Lending

 The fund

may

lend

its

securities

to

approved

borrowers

to

earn

additional

income.

Its

securities

lending

activities

are

administered

by

a

lending

agent

in

accordance

with

a

securities

lending

agreement.

Security

loans

generally

do

not

have

stated

maturity

dates,

and

the

fund

may

recall

a

security

at

any

time.

The

fund

receives

collateral

in

the

form

of

cash

or

U.S.

government

securities.

Collateral

is

maintained

T.

ROWE

PRICE

China

Evolution

Equity

Fund

30

over

the

life

of

the

loan

in

an

amount

not

less

than

the

value

of

loaned

securities;

any

additional

collateral

required

due

to

changes

in

security

values

is

delivered

to

the

fund

the

next

business

day.

Cash

collateral

is

invested

in

accordance

with

investment

guidelines

approved

by

fund

management.

Additionally,

the

lending

agent

indemnifies

the

fund

against

losses

resulting

from

borrower

default.

Although

risk

is

mitigated

by

the

collateral

and

indemnification,

the

fund

could

experience

a

delay

in

recovering

its

securities

and

a

possible

loss

of

income

or

value

if

the

borrower

fails

to

return

the

securities,

collateral

investments

decline

in

value,

and

the

lending

agent

fails

to

perform.

Securities

lending

revenue

consists

of

earnings

on

invested

collateral

and

borrowing

fees,

net

of

any

rebates

to

the

borrower,

compensation

to

the

lending

agent,

and

other

administrative

costs.

In

accordance

with

GAAP,

investments

made

with

cash

collateral

are

reflected

in

the

accompanying

financial

statements,

but

collateral

received

in

the

form

of

securities

is

not.

At

October

31,

2022,

the

value

of

loaned

securities

was

$585,000;

the

value

of

cash

collateral

and

related

investments

was

$613,000.

Other 

Purchases

and

sales

of

portfolio

securities

other

than

short-term securities

aggregated $40,719,000 and

$42,349,000,

respectively,

for

the

year ended

October

31,

2022.

NOTE

4

-

FEDERAL

INCOME

TAXES

Generally,

no

provision

for

federal

income

taxes

is

required

since

the

fund

intends

to

continue

to

qualify

as

a

regulated

investment

company

under

Subchapter

M

of

the

Internal

Revenue

Code

and

distribute

to

shareholders

all

of

its

taxable

income

and

gains.

Distributions

determined

in

accordance

with

federal

income

tax

regulations

may

differ

in

amount

or

character

from

net

investment

income

and

realized

gains

for

financial

reporting

purposes.

The fund

files

U.S.

federal,

state,

and

local

tax

returns

as

required. The

fund’s

tax

returns

are

subject

to

examination

by

the

relevant

tax

authorities

until

expiration

of

the

applicable

statute

of

limitations,

which

is

generally

three

years

after

the

filing

of

the

tax

return

but

which

can

be

extended

to

six

years

in

certain

circumstances.

Tax

returns

for

open

years

have

incorporated

no

uncertain

tax

positions

that

require

a

provision

for

income

taxes.

Capital

accounts

within

the

financial

reporting

records

are

adjusted

for

permanent

book/

tax

differences

to

reflect

tax

character

but

are

not

adjusted

for

temporary

differences.

The

permanent

book/tax

adjustments,

if

any,

have

no

impact

on

results

of

operations

or

T.

ROWE

PRICE

China

Evolution

Equity

Fund

31

net

assets.

The

permanent

book/tax

adjustments

relate

primarily

to

deemed

distributions

on

shareholder

redemptions,

the

character

of

net

currency

losses

and

the

differences

in

treatment

of

corporate

actions.

The

tax

character

of

distributions

paid

for

the

periods

presented

was

as

follows:

At

October

31,

2022,

the

tax-basis

cost

of

investments

(including

derivatives,

if

any)

and

gross

unrealized

appreciation

and

depreciation

were

as

follows:

At

October

31,

2022,

the

tax-basis

components

of

accumulated

net

earnings

(loss)

were

as

follows:

Temporary

differences

between

book-basis

and

tax-basis

components

of

total

distributable

earnings

(loss)

arise

when

certain

items

of

income,

gain,

or

loss

are

recognized

in

different

periods

for

financial

statement

purposes

versus

for

tax

purposes;

these

differences

will

reverse

in

a

subsequent

reporting

period.

The

temporary

differences

relate

primarily

to

the

deferral

of

losses

from

wash

sales,

the

realization

of

gains/losses

on

passive

foreign

investment

companies,

and

the

differences

in

treatment

($000s)

October

31,

2022

October

31,

2021

Ordinary

income

(including

short-term

capital

gains,

if

any)

$

2,307

‌

$

924

‌

Long-term

capital

gain

3,072

‌

—

‌

Total

distributions

$

5,379

‌

$

924

‌

($000s)

Cost

of

investments

$

66,259

‌

Unrealized

appreciation

$

3,548

‌

Unrealized

depreciation

(22,331

)

Net

unrealized

appreciation

(depreciation)

$

(18,783

)

($000s)

Undistributed

ordinary

income

$

1,325

‌

Net

unrealized

appreciation

(depreciation)

(18,783

)

Loss

carryforwards

and

deferrals

(9,944

)

Total

distributable

earnings

(loss)

$

(27,402

)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

32

of

corporate

actions.

The

loss

carryforwards

and

deferrals

primarily

relate

to

capital

loss

carryforwards. Capital

loss

carryforwards

are

available

indefinitely

to

offset

future

realized

capital

gains.

NOTE

5

-

FOREIGN  TAXES

The

fund

is

subject

to

foreign

income

taxes

imposed

by

certain

countries

in

which

it

invests.

Additionally,

capital

gains

realized

upon

disposition

of

securities

issued

in

or

by

certain

foreign

countries

are

subject

to

capital

gains

tax

imposed

by

those

countries.

All

taxes

are

computed

in

accordance

with

the

applicable

foreign

tax

law,

and,

to

the

extent

permitted,

capital

losses

are

used

to

offset

capital

gains.

Taxes

attributable

to

income

are

accrued

by

the

fund

as

a

reduction

of

income.

Current

and

deferred

tax

expense

attributable

to

capital

gains

is

reflected

as

a

component

of

realized

or

change

in

unrealized

gain/loss

on

securities

in

the

accompanying

financial

statements.

To

the

extent

that

the

fund

has

country

specific

capital

loss

carryforwards,

such

carryforwards

are

applied

against

net

unrealized

gains

when

determining

the

deferred

tax

liability.

Any

deferred

tax

liability

incurred

by

the

fund

is

included

in

either

Other

liabilities

or

Deferred

tax

liability

on

the

accompanying

Statement

of

Assets

and

Liabilities.

NOTE

6

-

RELATED

PARTY

TRANSACTIONS

The

fund

is

managed

by

T.

Rowe

Price

Associates,

Inc.

(Price

Associates),

a

wholly

owned

subsidiary

of

T.

Rowe

Price

Group,

Inc.

(Price

Group). Price

Associates

has

entered

into

a

sub-advisory

agreement(s)

with

one

or

more

of

its

wholly

owned

subsidiaries,

to

provide

investment

advisory

services

to

the

fund.

The

investment

management

agreement

between

the

fund

and

Price

Associates

provides

for

an

annual

investment

management

fee,

which

is

computed

daily

and

paid

monthly. The

fee

consists

of

an

individual

fund

fee,

equal

to

0.70%

of

the

fund’s

average

daily

net

assets,

and

a

group

fee.

The

group

fee

rate

is

calculated

based

on

the

combined

net

assets

of

certain

mutual

funds

sponsored

by

Price

Associates

(the

group)

applied

to

a

graduated

fee

schedule,

with

rates

ranging

from

0.48%

for

the

first

$1

billion

of

assets

to

0.260%

for

assets

in

excess

of

$845

billion.

The

fund’s

group

fee

is

determined

by

applying

the

group

fee

rate

to

the

fund’s

average

daily

net

assets. At

October

31,

2022,

the

effective

annual

group

fee

rate

was

0.29%.

The Investor Class

is

subject

to

a

contractual

expense

limitation

through

the

expense

limitation

date

indicated

in

the

table

below.

During

the

limitation

period,

Price

Associates

is

required

to

waive

its

management

fee

or

pay

any

expenses

(excluding

interest;

expenses

related

to

borrowings,

taxes,

and

brokerage;

non-recurring,

T.

ROWE

PRICE

China

Evolution

Equity

Fund

33

extraordinary expenses;

and

acquired

fund

fees

and

expenses) that

would

otherwise

cause

the

class’s

ratio

of

annualized

total

expenses

to

average

net

assets

(net

expense

ratio)

to

exceed

its

expense

limitation.

The

class

is

required

to

repay

Price

Associates

for

expenses

previously

waived/paid

to

the

extent

the

class’s

net

assets

grow

or

expenses

decline

sufficiently

to

allow

repayment

without

causing

the

class’s

net

expense

ratio

(after

the

repayment

is

taken

into

account)

to

exceed

the

lesser

of:

(1)

the

expense

limitation

in

place

at

the

time

such

amounts

were

waived;

or

(2)

the

class’s

current

expense

limitation.

However,

no

repayment

will

be

made

more

than

three

years

after

the

date

of

a

payment

or

waiver.  

The

I

Class

is

also

subject

to

an

operating

expense

limitation

(I

Class

Limit)

pursuant

to

which

Price

Associates

is

contractually

required

to

pay

all

operating

expenses

of

the

I

Class,

excluding

management

fees;

interest;

expenses

related

to

borrowings,

taxes,

and

brokerage; non-recurring,

extraordinary expenses; and

acquired

fund

fees

and

expenses, to

the

extent

such

operating

expenses,

on

an

annualized

basis,

exceed

the

I

Class

Limit. This

agreement

will

continue

through

the

expense

limitation

date

indicated

in

the

table

below,

and

may

be

renewed,

revised,

or

revoked

only

with

approval

of

the

fund’s

Board.

The

I

Class

is

required

to

repay

Price

Associates

for

expenses

previously

paid

to

the

extent

the

class’s

net

assets

grow

or

expenses

decline

sufficiently

to

allow

repayment

without

causing

the

class’s

operating

expenses

(after

the

repayment

is

taken

into

account)

to

exceed

the

lesser

of:

(1)

the

I

Class

Limit

in

place

at

the

time

such

amounts

were

paid;

or

(2)

the

current

I

Class

Limit.

However,

no

repayment

will

be

made

more

than

three

years

after

the

date

of

a

payment

or

waiver.

Pursuant

to

these

agreements,

expenses

were

waived/paid

by

and/or

repaid

to

Price

Associates

during

the

year ended October

31,

2022

as

indicated

in

the

table

below.

Including

this

amount,

expenses

previously

waived/paid

by

Price

Associates

in

the

amount

of $635,000 remain

subject

to

repayment

by

the

fund

at

October

31,

2022.

Any

repayment

of

expenses

previously

waived/paid

by

Price

Associates

during

the

period

would

be

included

in

the

net

investment

income

and

expense

ratios

presented

on

the

accompanying

Financial

Highlights.

Investor

Class

I

Class

Expense

limitation/I

Class

Limit

1.40%

0.05%

Expense

limitation

date

02/29/24

02/29/24

(Waived)/repaid

during

the

period

($000s)

$(188)

$(163)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

34

In

addition,

the

fund

has

entered

into

service

agreements

with

Price

Associates

and

a

wholly

owned

subsidiary

of

Price

Associates,

each

an

affiliate

of

the

fund

(collectively,

Price).

Price

Associates

provides

certain

accounting

and

administrative

services

to

the

fund.

T.

Rowe

Price

Services,

Inc.

provides

shareholder

and

administrative

services

in

its

capacity

as

the

fund’s

transfer

and

dividend-disbursing

agent.

For

the

year ended

October

31,

2022,

expenses

incurred

pursuant

to

these

service

agreements

were

$107,000 for

Price

Associates

and $127,000

for

T.

Rowe

Price

Services,

Inc.

All

amounts

due

to

and

due

from

Price,

exclusive

of

investment

management

fees

payable,

are

presented

net

on

the

accompanying

Statement

of

Assets

and

Liabilities.

The fund

may

invest

its

cash

reserves

in

certain

open-end

management

investment

companies

managed

by

Price

Associates

and

considered

affiliates

of

the

fund:

the

T.

Rowe

Price

Government

Reserve

Fund

or

the

T.

Rowe

Price

Treasury

Reserve

Fund,

organized

as

money

market

funds,

or

the

T.

Rowe

Price

Short-Term

Fund,

a

short-term

bond

fund

(collectively,

the

Price

Reserve

Funds).

The

Price

Reserve

Funds

are

offered

as

short-term

investment

options

to

mutual

funds,

trusts,

and

other

accounts

managed

by

Price

Associates

or

its

affiliates

and

are

not

available

for

direct

purchase

by

members

of

the

public.

Cash

collateral

from

securities

lending,

if

any,

is

invested

in

the

T.

Rowe

Price

Government

Reserve Fund;

prior

to

December

13,

2021,

the

cash

collateral

from

securities

lending

was

invested

in

the

T.

Rowe

Price

Short-Term

Fund.

The

Price

Reserve

Funds

pay

no

investment

management

fees. 

As

of

October

31,

2022,

T.

Rowe

Price

Group,

Inc.,

or

its

wholly

owned

subsidiaries,

owned

556,511

shares

of

the

I

Class,

representing

17%

of

the

I

Class's

net

assets.

The

fund may

participate

in

securities

purchase

and

sale

transactions

with

other

funds

or

accounts

advised

by

Price

Associates

(cross

trades),

in

accordance

with

procedures

adopted

by the

fund’s

Board

and

Securities

and

Exchange

Commission

rules,

which

require,

among

other

things,

that

such

purchase

and

sale

cross

trades

be

effected

at

the

independent

current

market

price

of

the

security.

During

the

year ended

October

31,

2022,

the

fund

had

no

purchases

or

sales

cross

trades

with

other

funds

or

accounts

advised

by

Price

Associates.

NOTE

7

-

OTHER

MATTERS

Unpredictable

events

such

as

environmental

or

natural

disasters,

war,

terrorism,

pandemics,

outbreaks

of

infectious

diseases,

and

similar

public

health

threats

may

significantly

affect

the

economy

and

the

markets

and

issuers

in

which

a

fund

invests.

Certain

events

may

cause

instability

across

global

markets,

including

reduced

liquidity

T.

ROWE

PRICE

China

Evolution

Equity

Fund

35

and

disruptions

in

trading

markets,

while

some

events

may

affect

certain

geographic

regions,

countries,

sectors,

and

industries

more

significantly

than

others,

and

exacerbate

other

pre-existing

political,

social,

and

economic

risks.

Since

2020,

a

novel

strain

of

coronavirus

(COVID-19)

has

resulted

in

disruptions

to

global

business

activity

and

caused

significant

volatility

and

declines

in

global

financial

markets.

In

February

2022,

Russian

forces

entered

Ukraine

and

commenced

an

armed

conflict

leading

to

economic

sanctions

being

imposed

on

Russia

and

certain

of

its

citizens,

creating

impacts

on

Russian-related

stocks

and

debt

and

greater

volatility

in

global

markets.

These

are

recent

examples

of

global

events

which

may

have

a

negative

impact

on

the

values

of

certain

portfolio

holdings

or

the

fund’s

overall

performance. Management

is

actively

monitoring

the

risks

and

financial

impacts

arising

from

these

events.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

36

REPORT

OF

INDEPENDENT

REGISTERED

PUBLIC

ACCOUNTING

FIRM

To

the

Board

of

Directors

of

T.

Rowe

Price

International

Funds,

Inc.

and

Shareholders

of

T.

Rowe

Price

China

Evolution

Equity

Fund

Opinion

on

the

Financial

Statements

We

have

audited

the

accompanying

statement

of

assets

and

liabilities,

including

the

portfolio

of

investments,

of

T.

Rowe

Price

China

Evolution

Equity

Fund

(one

of

the

funds

constituting

T.

Rowe

Price

International

Funds,

Inc.,

referred

to

hereafter

as

the

"Fund")

as

of

October

31,

2022,

the

related

statement

of

operations

for

the

year

ended

October

31,

2022,

the

statement

of

changes

in

net

assets

for

each

of

the

two

years

in

the

period

ended

October

31,

2022,

including

the

related

notes,

and

the

financial

highlights

for

each

of

the

years

ended

October

31,

2022

and

2021,

and

for

the

period

December

10,

2019

(Inception)

through

October

31,

2020

(collectively

referred

to

as

the

“financial

statements”).

In

our

opinion,

the

financial

statements

present

fairly,

in

all

material

respects,

the

financial

position

of

the

Fund

as

of

October

31,

2022,

the

results

of

its

operations

for

the

year

ended

October

31,

2022,

the

changes

in

its

net

assets

for

each

of

the

two

years

in

the

period

ended

October

31,

2022

and

the

financial

highlights

for

each

of

the

years

ended

October

31,

2022

and

2021

and

for

the

period

December

10,

2019

(Inception)

through

October

31,

2020

in

conformity

with

accounting

principles

generally

accepted

in

the

United

States

of

America.

Basis

for

Opinion

These

financial

statements

are

the

responsibility

of

the

Fund’s

management.

Our

responsibility

is

to

express

an

opinion

on

the

Fund’s

financial

statements

based

on

our

audits.

We

are

a

public

accounting

firm

registered

with

the

Public

Company

Accounting

Oversight

Board

(United

States)

(PCAOB)

and

are

required

to

be

independent

with

respect

to

the

Fund

in

accordance

with

the

U.S.

federal

securities

laws

and

the

applicable

rules

and

regulations

of

the

Securities

and

Exchange

Commission

and

the

PCAOB.

We

conducted

our

audits

of

these

financial

statements

in

accordance

with

the

standards

of

the

PCAOB.

Those

standards

require

that

we

plan

and

perform

the

audit

to

obtain

reasonable

assurance

about

whether

the

financial

statements

are

free

of

material

misstatement,

whether

due

to

error

or

fraud.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

37

Our

audits

included

performing

procedures

to

assess

the

risks

of

material

misstatement

of

the

financial

statements,

whether

due

to

error

or

fraud,

and

performing

procedures

that

respond

to

those

risks.

Such

procedures

included

examining,

on

a

test

basis,

evidence

regarding

the

amounts

and

disclosures

in

the

financial

statements.

Our

audits

also

included

evaluating

the

accounting

principles

used

and

significant

estimates

made

by

management,

as

well

as

evaluating

the

overall

presentation

of

the

financial

statements.

Our

procedures

included

confirmation

of

securities

owned

as

of

October

31,

2022

by

correspondence

with

the

custodian

and

transfer

agent.

We

believe

that

our

audits

provide

a

reasonable

basis

for

our

opinion.

PricewaterhouseCoopers

LLP

Baltimore,

Maryland

December

16,

2022

We

have

served

as

the

auditor

of

one

or

more

investment

companies

in

the

T.

Rowe

Price

group

of

investment

companies

since

1973.

REPORT

OF

INDEPENDENT

REGISTERED

PUBLIC

ACCOUNTING

FIRM

(continued)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

38

TAX

INFORMATION

(UNAUDITED)

FOR

THE

TAX

YEAR

ENDED 10/31/22

We

are

providing

this

information

as

required

by

the

Internal

Revenue

Code.

The

amounts

shown

may

differ

from

those

elsewhere

in

this

report

because

of

differences

between

tax

and

financial

reporting

requirements.

The

fund’s

distributions

to

shareholders

included:

$2,307,000 from

short-term

capital

gains 

$3,072,000 from

long-term

capital

gains,

subject

to

a

long-term

capital

gains

tax

rate

of

not

greater

than

20%

For

taxable

non-corporate

shareholders,

$427,000 of

the

fund's

income

represents

qualified

dividend

income

subject

to

a

long-term

capital

gains

tax

rate

of

not

greater

than

20%.

For

corporate

shareholders,

$5,000

of

the

fund's

income

qualifies

for

the

dividends-

received

deduction.  

The

fund

will

pass

through

foreign

source

income

of

$658,000

and

foreign

taxes

paid

of

$41,000.  

T.

ROWE

PRICE

China

Evolution

Equity

Fund

39

INFORMATION

ON

PROXY

VOTING

POLICIES,

PROCEDURES,

AND

RECORDS

A

description

of

the

policies

and

procedures

used

by

T.

Rowe

Price

funds

to

determine

how

to

vote

proxies

relating

to

portfolio

securities

is

available

in

each

fund’s

Statement

of

Additional

Information.

You

may

request

this

document

by

calling

1-800-225-5132

or

by

accessing

the

SEC’s

website,

sec.gov.

The

description

of

our

proxy

voting

policies

and

procedures

is

also

available

on

our

corporate

website.

To

access

it,

please

visit

the

following

Web

page:

https://www.troweprice.com/corporate/us/en/utility/policies.html

Scroll

down

to

the

section

near

the

bottom

of

the

page

that

says,

“Proxy

Voting

Guidelines.”

Click

on

the

links

in

the

shaded

box.

Each

fund’s

most

recent

annual

proxy

voting

record

is

available

on

our

website

and

through

the

SEC’s

website.

To

access

it

through

T.

Rowe

Price,

visit

the

website

location

shown

above,

and

scroll

down

to

the

section

near

the

bottom

of

the

page

that

says,

“Proxy

Voting

Records.”

Click

on

the

Proxy

Voting

Records

link

in

the

shaded

box.

HOW

TO

OBTAIN

QUARTERLY

PORTFOLIO

HOLDINGS

The

fund

files

a

complete

schedule

of

portfolio

holdings

with

the

Securities

and

Exchange

Commission

(SEC)

for

the

first

and

third

quarters

of

each

fiscal

year

as

an

exhibit

to

its

reports

on

Form

N-PORT.

The

fund’s

reports

on

Form

N-PORT

are

available

electronically

on

the

SEC’s

website

(sec.gov).

In

addition,

most

T.

Rowe

Price

funds

disclose

their

first

and

third

fiscal

quarter-end

holdings

on

troweprice.com

.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

40

LIQUIDITY

RISK

MANAGEMENT

PROGRAM

In

accordance

with

Rule

22e-4

(Liquidity

Rule)

under

the

Investment

Company

Act

of

1940,

as

amended,

the

fund

has

established

a

liquidity

risk

management

program

(Liquidity

Program)

reasonably

designed

to

assess

and

manage

the

fund’s

liquidity

risk,

which

generally

represents

the

risk

that

the

fund

would

not

be

able

to

meet

redemption

requests

without

significant

dilution

of

remaining

investors’

interests

in

the

fund.

The

fund’s

Board

of

Directors

(Board)

has

appointed

the

fund’s

investment

adviser,

T.

Rowe

Price

Associates,

Inc.

(Adviser),

as

the

administrator

of

the

Liquidity

Program.

As

administrator,

the

Adviser

is

responsible

for

overseeing

the

day-to-day

operations

of

the

Liquidity

Program

and,

among

other

things,

is

responsible

for

assessing,

managing,

and

reviewing

with

the

Board

at

least

annually

the

liquidity

risk

of

each

T.

Rowe

Price

fund.

The

Adviser

has

delegated

oversight

of

the

Liquidity

Program

to

a

Liquidity

Risk

Committee

(LRC),

which

is

a

cross-functional

committee

composed

of

personnel

from

multiple

departments

within

the

Adviser.

The

Liquidity

Program’s

principal

objectives

include

supporting

the

T.

Rowe

Price

funds’

compliance

with

limits

on

investments

in

illiquid

assets

and

mitigating

the

risk

that

the

fund

will

be

unable

to

timely

meet

its

redemption

obligations.

The

Liquidity

Program

also

includes

a

number

of

elements

that

support

the

management

and

assessment

of

liquidity

risk,

including

an

annual

assessment

of

factors

that

influence

the

fund’s

liquidity

and

the

periodic

classification

and

reclassification

of

a

fund’s

investments

into

categories

that

reflect

the

LRC’s

assessment

of

their

relative

liquidity

under

current

market

conditions.

Under

the

Liquidity

Program,

every

investment

held

by

the

fund

is

classified

at

least

monthly

into

one

of

four

liquidity

categories

based

on

estimations

of

the

investment’s

ability

to

be

sold

during

designated

time

frames

in

current

market

conditions

without

significantly

changing

the

investment’s

market

value.

As

required

by

the

Liquidity

Rule,

at

a

meeting

held

on

July

25,

2022,

the

Board

was

presented

with

an

annual

assessment

prepared

by

the

LRC,

on

behalf

of

the

Adviser,

that

addressed

the

operation

of

the

Liquidity

Program

and

assessed

its

adequacy

and

effectiveness

of

implementation,

including

any

material

changes

to

the

Liquidity

Program

and

the

determination

of

each

fund’s

Highly

Liquid

Investment

Minimum

(HLIM).

The

annual

assessment

included

consideration

of

the

following

factors,

as

applicable:

the

fund’s

investment

strategy

and

liquidity

of

portfolio

investments

during

normal

and

reasonably

foreseeable

stressed

conditions,

including

whether

the

investment

strategy

is

appropriate

for

an

open-end

fund,

the

extent

to

which

the

strategy

involves

a

relatively

concentrated

portfolio

or

large

positions

in

particular

issuers,

and

the

use

of

borrowings

for

investment

purposes

and

derivatives;

short-term

and

long-term

cash

flow

projections

covering

both

normal

and

reasonably

foreseeable

stressed

conditions;

and

holdings

of

cash

and

cash

equivalents,

as

well

as

available

borrowing

arrangements.

T.

ROWE

PRICE

China

Evolution

Equity

Fund

41

For

the

fund

and

other

T.

Rowe

Price

funds,

the

annual

assessment

incorporated

a

report

related

to

a

fund’s

holdings,

shareholder

and

portfolio

concentration,

any

borrowings

during

the

period,

cash

flow

projections,

and

other

relevant

data

for

the

period

of

April

1,

2021,

through

March

31,

2022.

The

report

described

the

methodology

for

classifying

a

fund’s

investments

(including

any

derivative

transactions)

into

one

of

four

liquidity

categories,

as

well

as

the

percentage

of

a

fund’s

investments

assigned

to

each

category.

It

also

explained

the

methodology

for

establishing

a

fund’s

HLIM

and

noted

that

the

LRC

reviews

the

HLIM

assigned

to

each

fund

no

less

frequently

than

annually.

During

the

period

covered

by

the

annual

assessment,

the

LRC

has

concluded,

and

reported

to

the

Board,

that

the

Liquidity

Program

continues

to

operate

adequately

and

effectively

and

is

reasonably

designed

to

assess

and

manage

the

fund’s

liquidity

risk.

LIQUIDITY

RISK

MANAGEMENT

PROGRAM

(continued)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

42

ABOUT

THE

FUND'S

DIRECTORS

AND

OFFICERS

Your

fund

is

overseen

by

a

Board

of

Directors

(Board)

that

meets

regularly

to

review

a

wide

variety

of

matters

affecting

or

potentially

affecting

the

fund,

including

performance,

investment

programs,

compliance

matters,

advisory

fees

and

expenses,

service

providers,

and

business

and

regulatory

affairs.

The

Board

elects

the

fund’s

officers,

who

are

listed

in

the

final

table.

The

directors

who

are

also

employees

or

officers

of

T.

Rowe

Price

are

considered

to

be

interested

directors

as

defined

in

Section

2(a)(19)

of

the

1940

Act

because

of

their

relationships

with

T.

Rowe

Price

and

its

affiliates.

The

business

address

of

each

director

and

officer

is

100

East

Pratt

Street,

Baltimore,

Maryland

21202.

The

Statement

of

Additional

Information

includes

additional

information

about

the

fund

directors

and

is

available

without

charge

by

calling

a

T.

Rowe

Price

representative

at

1-800-638-5660.

INDEPENDENT

DIRECTORS

(a)

Name

(Year

of

Birth)

Year

Elected

[Number

of

T.

Rowe

Price

Portfolios

Overseen]

Principal

Occupation(s)

and

Directorships

of

Public

Companies

and

Other

Investment

Companies

During

the

Past

Five

Years

Teresa

Bryce

Bazemore

(1959)

2018

[205]

President

and

Chief

Executive

Officer,

Federal

Home

Loan

Bank

of

San

Francisco

(2021

to

present);

President,

Radian

Guaranty

(2008

to

2017);

Chief

Executive

Officer,

Bazemore

Consulting

LLC

(2018

to

2021);

Director,

Chimera

Investment

Corporation

(2017

to

2021);

Director,

First

Industrial

Realty

Trust

(2020

to

present);

Director,

Federal

Home

Loan

Bank

of

Pittsburgh

(2017

to

2019)

Ronald

J.

Daniels

(b)

(1959)

2018

[0]

President,

The

Johns

Hopkins

University

and

Professor,

Political

Science

Department,

The

Johns

Hopkins

University

(2009

to

present);

Director,

Lyndhurst

Holdings

(2015

to

present);

Director,

BridgeBio

Pharma,

Inc.

(2020

to

present)

Bruce

W.

Duncan

(1951)

2013

[205]

President,

Chief

Executive

Officer,

and

Director,

CyrusOne,

Inc.

(2020

to

2021);

Chief

Executive

Officer

and

Director

(2009

to

2016),

Chair

of

the

Board

(2016

to

2020),

and

President

(2009

to

2016),

First

Industrial

Realty

Trust,

owner

and

operator

of

industrial

properties;

Chair

of

the

Board

(2005

to

2016)

and

Director

(1999

to

2016),

Starwood

Hotels

&

Resorts,

a

hotel

and

leisure

company;

Member,

Investment

Company

Institute

Board

of

Governors

(2017

to

2019);

Member,

Independent

Directors

Council

Governing

Board

(2017

to

2019);

Senior

Advisor,

KKR

(2018

to

present);

Director,

Boston

Properties

(2016

to

present);

Director,

Marriott

International,

Inc.

(2016

to

2020)

Robert

J.

Gerrard,

Jr.

(1952)

2012

[205]

Advisory

Board

Member,

Pipeline

Crisis/Winning

Strategies,

a

collaborative

working

to

improve

opportunities

for

young

African

Americans

(1997

to

2016);

Chair

of

the

Board,

all

funds

(July

2018

to

present)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

43

INTERESTED  DIRECTORS

(a)

Name

(Year

of

Birth)

Year

Elected

[Number

of

T.

Rowe

Price

Portfolios

Overseen]

Principal

Occupation(s)

and

Directorships

of

Public

Companies

and

Other

Investment

Companies

During

the

Past

Five

Years

Paul

F.

McBride

(1956)

2013

[205]

Advisory

Board

Member,

Vizzia

Technologies

(2015

to

present);

Board

Member,

Dunbar

Armored

(2012

to

2018)

Kellye

L.

Walker

(c)

(1966)

2021

[205]

Executive

Vice

President

and

Chief

Legal

Officer,

Eastman

Chemical

Company

(April

2020

to

present);

Executive

Vice

President

and

Chief

Legal

Officer,

Huntington

Ingalls

Industries,

Inc.

(January

2015

to

March

2020);

Director,

Lincoln

Electric

Company

(October

2020

to

present)

(a)

All

information

about

the

independent

directors

was

current

as

of

December

31,

2021,

unless

otherwise

indicated,

except

for

the

number

of

portfolios

overseen,

which

is

current

as

of

the

date

of

this

report.

(b)

Effective

April

27,

2022,

Mr.

Daniels

resigned

from

his

role

as

an

independent

director

of

the

Price

Funds.

(c)

Effective

November

8,

2021,

Ms.

Walker

was

appointed

as

an

independent

director

of

the

Price

Funds.

Name

(Year

of

Birth)

Year

Elected

[Number

of

T.

Rowe

Price

Portfolios

Overseen]

Principal

Occupation(s)

and

Directorships

of

Public

Companies

and

Other

Investment

Companies

During

the

Past

Five

Years

David

Oestreicher

(1967)

2018

[205]

Director,

Vice

President,

and

Secretary,

T.

Rowe

Price,

T.

Rowe

Price

Investment

Services,

Inc.,

T.

Rowe

Price

Retirement

Plan

Services,

Inc.,

and

T.

Rowe

Price

Services,

Inc.;

Director

and

Secretary,

T.

Rowe

Price

Investment

Management,

Inc.

(Price

Investment

Management);

Vice

President

and

Secretary,

T.

Rowe

Price

International

(Price

International);

Vice

President,

T.

Rowe

Price

Hong

Kong

(Price

Hong

Kong),

T. Rowe

Price

Japan

(Price

Japan),

and

T.

Rowe

Price

Singapore

(Price

Singapore);

General

Counsel,

Vice

President,

and

Secretary,

T.

Rowe

Price

Group,

Inc.;

Chair

of

the

Board,

Chief

Executive

Officer,

President,

and

Secretary,

T.

Rowe

Price

Trust

Company;

Principal

Executive

Officer

and

Executive

Vice

President,

all

funds

Robert

W.

Sharps,

CFA,

CPA

(b)

(1971)

2017

[0]

Director

and

Vice

President,

T.

Rowe

Price;

Director,

Price

Investment

Management;

Chief

Executive

Officer

and

President,

T.

Rowe

Price

Group,

Inc.;

Vice

President,

T.

Rowe

Price

Trust

Company;

Vice

President,

International

Funds

INDEPENDENT

DIRECTORS

(a)

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

44

OFFICERS

Name

(Year

of

Birth)

Year

Elected

[Number

of

T.

Rowe

Price

Portfolios

Overseen]

Principal

Occupation(s)

and

Directorships

of

Public

Companies

and

Other

Investment

Companies

During

the

Past

Five

Years

Eric

L.

Veiel,

CFA

(1972)

2022

[205]

Director

and

Vice

President,

T.

Rowe

Price;

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

(a)

All

information

about

the

interested

directors

was

current

as

of

January

1,

2022,

unless

otherwise

indicated,

except

for

the

number

of

portfolios

overseen,

which

is

current

as

of

the

date

of

this

report.

(b)

Effective

February

3,

2022,

Mr.

Sharps

resigned

from

his

role

as

an

interested

director

of

the

Price

Funds.

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Mariel

Abreu

(1981)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Jason

R.

Adams

(1979)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Ulle

Adamson,

CFA

(1979)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Roy

H.

Adkins

(1970)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Syed

H.

Ali

(1970)

Vice

President

Vice

President,

Price

Hong

Kong,

Price

Singapore,

and

T.

Rowe

Price

Group,

Inc.

Kennard

W.

Allen

(1977)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Paulina

Amieva

(1981)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Malik

S.

Asif

(1981)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Ziad

Bakri,

M.D.,

CFA

(1980)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Harishankar

Balkrishna

(1983)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Sheena

L.

Barbosa

(1983)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

INTERESTED  DIRECTORS

(a)

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

45

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Jason

A.

Bauer

(1979)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Luis

M.

Baylac

(1982)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

R.

Scott

Berg,

CFA

(1972)

Executive

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Steven

E.

Boothe,

CFA

(1977)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Peter

I.

Botoucharov

(1965)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Tala

Boulos

(1984)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Christopher

P.

Brown,

Jr., CFA

(1977)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Armando

(Dino)

Capasso

(1974)

Chief

Compliance

Officer

Chief

Compliance

Officer

and

Vice

President,

T.

Rowe

Price

and

Price

Investment

Management;

Vice

President,

T.

Rowe

Price

Group,

Inc.;

formerly,

Chief

Compliance

Officer,

PGIM

Investments

LLC

and

AST

Investment

Services,

Inc.

(ASTIS)

(to

2022);

Chief

Compliance

Officer,

PGIM

Retail

Funds

complex

and

Prudential

Insurance

Funds

(to

2022);

Vice

President

and

Deputy

Chief

Compliance

Officer,

PGIM

Investments

LLC

and

ASTIS

(to

2019);

Senior

Vice

President

and

Senior

Counsel, Pacific

Investment

Management

Company

LLC

(to

2017)

Shiu

Tak

(Sheldon)

Chan

(1981)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Andrew

Chang

(1983)

Vice

President

Vice

President,

Price

Singapore

and

T.

Rowe

Price

Group,

Inc.

Carolyn

Hoi

Che

Chu

(1974)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Vincent

Chung

(1988)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International;

formerly,

Investment

Analyst/Trader,

Observatory

Capital

Management

LLP

(to

2019)

Archibald

Ciganer,

CFA

(1976)

Executive

Vice

President

Director

and

Vice

President,

Price

Japan;

Vice

President,

T.

Rowe

Price

Group,

Inc.

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

46

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Richard

N.

Clattenburg,

CFA

(1979)

Executive

Vice

President

Vice

President,

Price

Singapore,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

Price

International,

and

T.

Rowe

Price

Trust

Company

Michael

F.

Connelly,

CFA

(1977)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Richard

de

los

Reyes

(1975)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Michael

Della

Vedova

(1969)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Iona

Dent,

CFA

(1991)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International;

formerly,

Associate,

Equity

Research,

Deutsche

Bank

(to

2018)

Maria

Elena

Drew

(1973)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Shawn

T.

Driscoll

(1975)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Alan

S.

Dupski,

CPA

(1982)

Principal

Financial

Officer,

Vice

President,

and

Treasurer

Vice

President,

Price

Investment

Management,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Bridget

A.

Ebner

(1970)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

David

J.

Eiswert,

CFA

(1972)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Dawei

Feng

(1979)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.; formerly,

Head

of

China

Consumer

in

Equity

Research,

Credit Lyonnais

Asia-Pacific

(to

2018)

Ryan

W.

Ferro

(1985)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Mark

S.

Finn,

CFA,

CPA

(1963)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Quentin

S.

Fitzsimmons

(1968)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Justin

T.

Gerbereux,

CFA

(1975)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Aaron

Gifford,

CFA

(1987)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

47

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Vishnu

V.

Gopal

(1979)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Joel

Grant

(1978)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Gary

J.

Greb

(1961)

Vice

President

Vice

President,

Price

Investment

Management,

T.

Rowe

Price,

Price

International,

and

T.

Rowe

Price

Trust

Company

Benjamin

Griffiths,

CFA

(1977)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Gianluca

Guicciardi

(1983)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Shaoyu

Guo

(1992)

Vice

President

Vice

President,

Price

Hong

Kong;

formerly,

Economist,

J.P.

Morgan

(to

2020)

Richard

L.

Hall

(1979)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Cheryl

Hampton,

CPA

(1969)

Vice

President

Vice

President,

T.

Rowe

Price;

formerly,

Tax

Director,

Invesco

Ltd.

(to

2021);

Vice

President,

Oppenheimer

Funds,

Inc.

(to

2019)

Nabil

Hanano,

CFA

(1984)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Jeffrey

Holford,

Ph.D.,

ACA

(1972)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.;

formerly,

Managing

Director,

Jeffries

Financial

Group

(to

2018)

Stefan

Hubrich,

Ph.D.,

CFA

(1974)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Arif

Husain,

CFA

(1972)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Tetsuji

Inoue

(1971)

Vice

President

Vice

President,

Price

Hong

Kong,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Michael

D.

Jacobs

(1971)

Vice

President

Vice

President,

Price

Japan,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Randal

S.

Jenneke

(1971)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.

Prashant

G.

Jeyaganesh

(1983)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Nina

P.

Jones,

CPA

(1980)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

48

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Yoichiro

Kai

(1973)

Vice

President

Vice

President,

Price

Singapore,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Jacob

H.

Kann,

CFA

(1987)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Jai

Kapadia

(1982)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Andrew

J.

Keirle

(1974)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Benjamin

Kersse,

CPA

(1989)

Vice

President

Vice

President,

T.

Rowe

Price

Takanori

Kobayashi

(1981)

Vice

President

Vice

President,

Price

Japan,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Paul

J.

Krug,

CPA

(1964)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Christopher

J.

Kushlis,

CFA

(1976)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Shengrong

Lau

(1982)

Vice

President

Vice

President,

Price

Singapore

and

T.

Rowe

Price

Group,

Inc.

Lu

Liu

(1979)

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Johannes

Loefstrand

(1988)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Anh Lu

(1968)

Executive

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Sebastien

Mallet

(1974)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Jennifer Martin

(1972)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Ryan

Martyn

(1979)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Colin

McQueen

(1967)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International;

formerly,

Senior

Investment

Manager,

Global

Equities,

Sanlam

FOUR

Investments

UK

Limited

(to

2019)

Raymond

A.

Mills,

Ph.D.,

CFA

(1960)

Executive

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

Price

International,

and

T.

Rowe

Price

Trust

Company

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

49

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Jihong

Min

(1979)

Executive

Vice

President

Vice

President,

Price

Singapore

and

T.

Rowe

Price

Group,

Inc.

Eric

C.

Moffett

(1974)

Executive

Vice

President

Vice

President,

Price

Singapore

and

T.

Rowe

Price

Group,

Inc.

Ivan

Morozov,

CFA

(1987)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Samy

B.

Muaddi,

CFA

(1984)

Executive

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Tobias

F.

Mueller,

CFA

(1980)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Razan

Nasser

(1985)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International;

formerly,

Senior

Economist,

HSBC

Bank

Middle

East

Ltd

(to

2019)

Philip

A.

Nestico

(1976)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Sridhar

Nishtala

(1975)

Vice

President

Director

and

Vice

President,

Price

Singapore;

Vice

President,

T.

Rowe

Price

Group,

Inc.

Kenneth

A.

Orchard

(1975)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Oluwaseun

A.

Oyegunle,

CFA

(1984)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Fran

M.

Pollack-Matz

(1961)

Vice

President

and

Secretary 

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

T.

Rowe

Price

Investment

Services,

Inc.,

and

T.

Rowe

Price

Services,

Inc.

Shannon

H.

Rauser

(1987)

Assistant

Secretary 

Assistant

Vice

President,

T.

Rowe

Price

Todd

Reese

(1990)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Melanie

A.

Rizzo

(1982)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

David

L.

Rowlett,

CFA

(1975)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Federico

Santilli,

CFA

(1974)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Nikolaj

Schmidt

(1975)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and Price

International

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

50

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Sebastian

Schrott

(1977)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Bin

Shen,

CFA

(1987)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

John

C.A.

Sherman

(1969)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Weijie

(Vivian)

Si

(1983)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Scott

D.

Solomon,

CFA

(1981)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Joshua

K.

Spencer,

CFA

(1973)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

David

Stanley

(1963)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Saurabh

Sud,

CFA

(1985)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.;

formerly,

Senior

Vice

President,

PIMCO

(to

2018)

Taymour

R.

Tamaddon,

CFA

(1976)

Vice

President

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

and

T.

Rowe

Price

Trust

Company

Ju

Yen

Tan

(1972)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Sin

Dee

Tan,

CFA

(1979)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Siby

Thomas

(1979)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Justin

Thomson

(1968)

President

Director,

Price

Hong

Kong;

Vice

President,

T.

Rowe

Price

Group,

Inc.;

Director

and

Vice

President,

Price

International

Willem

Visser

(1979)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Christopher Vost

(1989)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Zenon

Voyiatzis

(1971)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Verena

E.

Wachnitz,

CFA

(1978)

Executive

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

ROWE

PRICE

China

Evolution

Equity

Fund

51

Name

(Year

of

Birth)

Position

Held

With International

Funds 

Principal

Occupation(s) 

Megan

Warren

(1968)

Vice

President

OFAC

Sanctions

Compliance

Officer

and

Vice

President,

Price

Investment

Management;

Vice

President,

T.

Rowe

Price,

T.

Rowe

Price

Group,

Inc.,

T.

Rowe

Price

Retirement

Plan

Services,

Inc.,

T.

Rowe

Price

Services,

Inc.,

and

T.

Rowe

Price

Trust

Company

Hiroshi

Watanabe,

CFA

(1975)

Vice

President

Director

and

Vice

President,

Price

Japan;

Vice

President,

T.

Rowe

Price

Group,

Inc. 

James

Woodward,

CFA

(1974)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Marta

Yago

(1977)

Vice

President

Vice

President,

T.

Rowe

Price

Group,

Inc.,

and

Price

International

Benjamin

T.

Yeagle

(1978)

Vice

President

Vice

President,

T.

Rowe

Price

and

T.

Rowe

Price

Group,

Inc.

Ernest

C.

Yeung,

CFA

(1979)

Executive

Vice

President

Director

and

Vice

President,

Price

Hong

Kong;

Vice

President,

T.

Rowe

Price

Group,

Inc.

Wenli

Zheng

(1979)

Executive

Vice

President

Vice

President,

Price

Hong

Kong

and

T.

Rowe

Price

Group,

Inc.

Unless

otherwise

noted,

officers

have

been

employees

of

T.

Rowe

Price

or

Price

International

for

at

least

5

years.

OFFICERS

(CONTINUED)

T.

Rowe

Price

Investment

Services,

Inc.

|

100

East

Pratt

Street

|

Baltimore,

MD

21202-1009

You

have

many

investment

goals.

Explore

products

and

services

that

can

help

you

achieve

them.

Whether

you

want

to

put

away

more

money

for

retirement,

for

a

child’s

education,

or

for

other

priorities,

we

have

solutions

for

you.

See

how

we

can

help

you

accomplish

the

investment

goals

that

are

important

to

you.

RETIREMENT

IRAs:

Traditional,

Roth,

Rollover/Transfer,

or

Brokerage

Small

Business

Plans

help

minimize

taxes,

maximize

savings

T.

Rowe

Price

®

ActivePlus

Portfolios

1

for

online

investing

powered

by

experts

GENERAL

INVESTING

Individual

or

Joint

Tenant

Brokerage

2

offers

access

to

stocks,

ETFs,

bonds,

and

more

Gifts

and

transfers

to

a

child

(UGMA/UTMAs)

Trust

Transfer

on

Death

COLLEGE

SAVINGS

T.

Rowe

Price-managed

529

plans

offer

tax-

advantaged

solutions

for

families

saving

money

for

college

tuition

and

education-

related

expenses

Visit

troweprice.com/broadrange

Call

1-800-225-5132

to

request

a

prospectus

or

summary

prospectus;

each

includes

investment

objectives,

risks,

fees,

expenses,

and

other

information

that

you

should

read

and

consider

carefully

before

investing.

All

mutual

funds

are

subject

to

market

risk,

including

possible

loss

of

principal.

Investing

internationally

involves

special

risks

including

economic

and

political

uncertainty

and

currency

fluctuation.

1

The

T.

Rowe

Price

®

ActivePlus

Portfolios

is

a

discretionary

investment

management

program

provided

by

T.

Rowe

Price

Advisory

Services,

Inc.,

a

registered

investment

adviser

under

the

Investment

Advisers

Act

of

1940.

Brokerage

services

are

provided

by

T.

Rowe

Price

Investment

Services,

Inc.,

member

FINRA/SIPC.

Brokerage

accounts

are

carried

by

Pershing

LLC,

a

BNY

Mellon

Company,

member

NYSE/FINRA/SIPC.

T.

Rowe

Price

Advisory

Services,

Inc.,

and

T.

Rowe

Price

Investment

Services,

Inc.,

are

affiliated

companies.

2

Brokerage

services

are

provided

by

T.

Rowe

Price

Investment

Services,

Inc.,

member

FINRA/SIPC.

Brokerage

accounts

are

carried

by

Pershing

LLC,

a

BNY

Mellon

Company,

member

NYSE/FINRA/SIPC.

202212-2401184

F1228-050

12/22

Item 1.  (b) Notice pursuant to Rule 30e-3.

Not applicable.

Item 2.  Code of Ethics.

The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.

Item 3.  Audit Committee Financial Expert.

The registrant’s Board of Directors has determined that Ms. Teresa Bryce Bazemore qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Ms. Bazemore is considered independent for purposes of Item 3 of Form N-CSR.

Item 4.  Principal Accountant Fees and Services.

(a) – (d)  Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:

	2022		2021
Audit Fees	$	24,349	$	23,048
Audit-Related Fees		-		-
Tax Fees		-		2,840
All Other Fees		-		-

Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.

(e)(1)  The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.

(2)  No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

(f)  Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

(g)  The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $2,760,000 and $3,600,000, respectively.

(h)  All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.

Item 5.  Audit Committee of Listed Registrants.

Not applicable.

Item 6.  Investments.

(a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.

(b) Not applicable.

Item 7.  Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8.  Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9.  Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10.  Submission of Matters to a Vote of Security Holders.

There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.

Item 11.  Controls and Procedures.

(a)  The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.

(b)  The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12.  Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 13.   Exhibits.

(a)(1)  The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is attached.

(2)   Separate certifications by the registrant’s principal executive officer and principal financial officer, pursuant to Section  302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.

(3)  Written solicitation to repurchase securities issued by closed-end companies: not applicable.

(b)   A certification by the registrant’s principal executive officer and principal financial officer, pursuant to Section  906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

T. Rowe Price International Funds, Inc.
By	/s/ David Oestreicher
	David Oestreicher
	Principal Executive Officer
Date	December 16, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By	/s/ David Oestreicher
	David Oestreicher
	Principal Executive Officer
Date	December 16, 2022

By	/s/ Alan S. Dupski
	Alan S. Dupski
	Principal Financial Officer
Date	December 16, 2022